{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:39:44Z","timestamp":1792723184424,"version":"4.5.0"},"reference-count":241,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":91,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"DOI":"10.1186\/s13023-026-04513-0","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T09:25:03Z","timestamp":1784885103000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The new frontier of newborn screening: integrating genomics, metabolomics, and data science for inborn errors of metabolism"],"prefix":"10.1186","volume":"21","author":[{"given":"Muhammad","family":"Wasim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoda","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"3","key":"4513_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/metabo13030447","volume":"13","author":"M Cossu","year":"2023","unstructured":"Cossu M, Pintus R, Zaffanello M, Mussap M, Serra F, Marcialis MA, et al. Metabolomic studies in inborn errors of metabolism: last years and future perspectives. Metabolites. 2023;13(3):13. https:\/\/doi.org\/10.3390\/metabo13030447.","journal-title":"Metabolites"},{"issue":"1","key":"4513_CR2","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1038\/s41598-021-81897-y","volume":"11","author":"R Zhang","year":"2021","unstructured":"Zhang R, Qiang R, Song C, Ma X, Zhang Y, Li F, et al. Spectrum analysis of inborn errors of metabolism for expanded newborn screening in a northwestern Chinese population. Sci Rep. 2021;11(1):2699. https:\/\/doi.org\/10.1038\/s41598-021-81897-y.","journal-title":"Sci Rep"},{"issue":"8","key":"4513_CR3","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1001\/jamapediatrics.2015.0754","volume":"169","author":"HJ Vernon","year":"2015","unstructured":"Vernon HJ. Inborn errors of metabolism: advances in diagnosis and therapy. JAMA Pediatr. 2015;169(8):778\u201382. https:\/\/doi.org\/10.1001\/jamapediatrics.2015.0754.","journal-title":"JAMA Pediatr"},{"issue":"5","key":"4513_CR4","doi-asserted-by":"publisher","first-page":"473","DOI":"10.5152\/TurkArchPediatr.2022.16082022","volume":"57","author":"A Aktu\u011flu Zeybek","year":"2022","unstructured":"Aktu\u011flu Zeybek A. Newborn screening: from the past to the future. Turk Arch Pediat. 2022;57(5):473\u201375. https:\/\/doi.org\/10.5152\/TurkArchPediatr.2022.16082022.","journal-title":"Turk Arch Pediatrics"},{"issue":"4","key":"4513_CR5","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/s41390-024-03689-0","volume":"97","author":"M Mori","year":"2025","unstructured":"Mori M, Chaudhari BP, Ream MA, Kemper AR. Promises and challenges of genomic newborn screening (NBS): lessons from public health NBS programs. Pediatr Res. 2025;97(4):1327\u201336. https:\/\/doi.org\/10.1038\/s41390-024-03689-0.","journal-title":"Pediatr Res"},{"key":"4513_CR6","doi-asserted-by":"publisher","unstructured":"Chien Y-H, Hwu W-L. The modern face of newborn screening. Pediatr Neonatol. 2023;64:S22\u201329. https:\/\/doi.org\/10.1016\/j.pedneo.2022.11.001.","DOI":"10.1016\/j.pedneo.2022.11.001"},{"issue":"3","key":"4513_CR7","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1542\/peds.32.3.338","volume":"32","author":"R Guthrie","year":"1963","unstructured":"Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics. 1963;32(3):338\u201343. https:\/\/doi.org\/10.1542\/peds.32.3.338.","journal-title":"Pediatrics"},{"issue":"6","key":"4513_CR8","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3109\/10408363.2013.847896","volume":"50","author":"CM Mak","year":"2013","unstructured":"Mak CM, Lee H-CH, Chan AY-W, Lam CW. Inborn errors of metabolism and expanded newborn screening: review and update. Crit Rev Clin Lab Sci. 2013;50(6):142\u201362. https:\/\/doi.org\/10.3109\/10408363.2013.847896.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"4513_CR9","doi-asserted-by":"publisher","first-page":"117797","DOI":"10.1016\/j.cca.2024.117797","volume":"555","author":"S Yu","year":"2024","unstructured":"Yu S, Zou Y, Ma X, Wang D, Luo W, Tang Y, et al. Evolution of LC\u2013MS\/MS in clinical laboratories. Clin Chim Acta. 2024;555:117797. https:\/\/doi.org\/10.1016\/j.cca.2024.117797.","journal-title":"Clinica (Rome) Acta"},{"issue":"1","key":"4513_CR10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s43586-022-00175-x","volume":"2","author":"SN Thomas","year":"2022","unstructured":"Thomas SN, French D, Jannetto PJ, Rappold BA, Clarke WA. Liquid chromatography\u2013tandem mass spectrometry for clinical diagnostics. Nat Rev Methods Primers. 2022;2(1):96. https:\/\/doi.org\/10.1038\/s43586-022-00175-x.","journal-title":"Nat Rev Methods Primers"},{"issue":"3","key":"4513_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/BF01799385","volume":"13","author":"DS Millington","year":"1990","unstructured":"Millington DS, Kodo N, Norwood DL, Roe CR. Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis. 1990;13(3):321\u201324. https:\/\/doi.org\/10.1007\/BF01799385.","journal-title":"J Inher Metab Disea"},{"issue":"4","key":"4513_CR12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ped4.12343","volume":"6","author":"S Ding","year":"2022","unstructured":"Ding S, Han L. Newborn screening for genetic disorders: current status and prospects for the future. Pediatr Investig. 2022;6(4):291\u201398. https:\/\/doi.org\/10.1002\/ped4.12343.","journal-title":"Pediatr Investigation"},{"key":"4513_CR13","doi-asserted-by":"publisher","unstructured":"Jiang S, Wang H, Gu Y. Genome sequencing for newborn screening\u2014an effective approach for tackling rare diseases. JAMA Netw Open. 2023;6(9):e2331141\u201341. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.31141.","DOI":"10.1001\/jamanetworkopen.2023.31141"},{"issue":"2","key":"4513_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/jms.1528","volume":"44","author":"DH Chace","year":"2009","unstructured":"Chace DH. Mass spectrometry in newborn and metabolic screening: historical perspective and future directions. J Mass Spectrom. 2009;44(2):163\u201370. https:\/\/doi.org\/10.1002\/jms.1528.","journal-title":"J Mass Spectrom"},{"issue":"1","key":"4513_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/1099800415595463","volume":"18","author":"S Li","year":"2016","unstructured":"Li S, Dunlop AL, Jones DP, Corwin EJ. High-resolution metabolomics: review of the field and implications for nursing science and the study of preterm birth. Biol Res Nurs. 2016;18(1):12\u201322. https:\/\/doi.org\/10.1177\/1099800415595463.","journal-title":"Biol Res Nurs"},{"issue":"1","key":"4513_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/metabo16010049","volume":"16","author":"D Sahu","year":"2026","unstructured":"Sahu D, Matusa AM, DiBattista A, Urquhart BL, Fraser DD. Mass spectrometry-based metabolomics in pediatric health and disease. Metabolites. 2026;16(1):16. https:\/\/doi.org\/10.3390\/metabo16010049.","journal-title":"Metabolites"},{"issue":"24","key":"4513_CR17","doi-asserted-by":"publisher","first-page":"5934","DOI":"10.3390\/molecules29245934","volume":"29","author":"NK Anh","year":"2024","unstructured":"Anh NK, Thu NQ, Tien NTN, Long NP, Nguyen HT. Advancements in Mass spectrometry-based targeted metabolomics and lipidomics: implications for clinical research. Molecules. 2024;29(24):5934. https:\/\/doi.org\/10.3390\/molecules29245934.","journal-title":"Molecules"},{"issue":"7","key":"4513_CR18","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nrd.2016.32","volume":"15","author":"DS Wishart","year":"2016","unstructured":"Wishart DS. Emerging applications of metabolomics in drug discovery and precision medicine. Nat Rev Drug Discov. 2016;15(7):473\u201384. https:\/\/doi.org\/10.1038\/nrd.2016.32.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"4513_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrm3314","volume":"13","author":"GJ Patti","year":"2012","unstructured":"Patti GJ, Yanes O, Siuzdak G. Innovation: metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol. 2012;13(4):263\u201369. https:\/\/doi.org\/10.1038\/nrm3314.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"4513_CR20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10545-017-0131-6","volume":"41","author":"KLM Coene","year":"2018","unstructured":"Coene KLM, Kluijtmans LAJ, van der Heeft E, Engelke UFH, de Boer S, Hoegen B, et al. Next-generation metabolic screening: targeted and untargeted metabolomics for the diagnosis of inborn errors of metabolism in individual patients. J Inherit Metab Dis. 2018;41(3):337\u201353. https:\/\/doi.org\/10.1007\/s10545-017-0131-6.","journal-title":"J Inher Metab Disea"},{"issue":"11","key":"4513_CR21","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.3390\/diagnostics16111717","volume":"16","author":"SA Osman","year":"2026","unstructured":"Osman SA, Malki A, Al-Sulaiti H, Al-Dirbashi OY, Elrayess MA. Emerging quantitative targeted metabolomics approaches for future inborn errors of metabolism screening. Diagnostics. 2026;16(11):1717. https:\/\/doi.org\/10.3390\/diagnostics16111717.","journal-title":"Diagnostics"},{"issue":"3","key":"4513_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/ijns10030062","volume":"10","author":"E Schnabel-Besson","year":"2024","unstructured":"Schnabel-Besson E, M\u00fctze U, Dikow N, H\u00f6rster F, Morath MA, Alex K, et al. Wilson and Jungner revisited: are screening criteria fit for the 21st century? Int J Neonatal Screen. 2024;10(3):10. https:\/\/doi.org\/10.3390\/ijns10030062.","journal-title":"IJNS"},{"issue":"5","key":"4513_CR23","doi-asserted-by":"publisher","first-page":"674","DOI":"10.18553\/jmcp.2021.27.5.674","volume":"27","author":"LP Garrison Jr","year":"2021","unstructured":"Garrison LP Jr, Jiao B, Dabbous O. Gene therapy may not be as expensive as people think: challenges in assessing the value of single and short-term therapies. J Manag Care Spec Pharm. 2021;27(5):674\u201381. https:\/\/doi.org\/10.18553\/jmcp.2021.27.5.674.","journal-title":"JMCP"},{"issue":"1","key":"4513_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12017-025-08855-z","volume":"27","author":"S Vankwani","year":"2025","unstructured":"Vankwani S, Mirza MR, Tahir M, Wasim M, Rajput SA, Khan HN, et al. Exploring proteomic alterations in intellectual disability: insights from hyperlipidemia and hyperphosphatasia subgroups. NeuroMolecular Med. 2025;27(1):38. https:\/\/doi.org\/10.1007\/s12017-025-08855-z.","journal-title":"NeuroMol Med"},{"issue":"2","key":"4513_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1134\/S1819712425700254","volume":"19","author":"I Javed","year":"2025","unstructured":"Javed I, Khan HN, Sultan T, Wasim M. Phenotypic and genotypic landscape of epileptic encephalopathies in children with seven novel variants: a single tertiary care hospital experience. Neurochem J. 2025;19(2):217\u201326. https:\/\/doi.org\/10.1134\/S1819712425700254.","journal-title":"Neurochem J"},{"issue":"5","key":"4513_CR26","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s11011-024-01351-6","volume":"39","author":"S Vankwani","year":"2024","unstructured":"Vankwani S, Mirza MR, Awan FR, Zafar M, Nawrocki A, Wasim M, et al. Label free quantitative proteomic profiling of serum samples of intellectually disabled young patients revealed dysregulation of complement coagulation and cholesterol cascade systems. Metab Brain Dis. 2024;39(5):855\u201369. https:\/\/doi.org\/10.1007\/s11011-024-01351-6.","journal-title":"Metab Brain Dis"},{"issue":"6","key":"4513_CR27","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1080\/15257770.2023.2280013","volume":"43","author":"A Khalil","year":"2024","unstructured":"Khalil A, Khan HN, Wasim M, Ayesha H, Awan FR. Development of low-cost in-house tetra-ARMS-PCR assay for the screening of five CBS mutations found in Pakistani homocystinuria patients. Nucleosides Nucleotides Nucleic Acids. 2024;43(6):517\u201329. https:\/\/doi.org\/10.1080\/15257770.2023.2280013.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"4","key":"4513_CR28","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1134\/S1819712424700521","volume":"18","author":"I Javed","year":"2024","unstructured":"Javed I, Wasim M, Khan HN, Sultan T. Exploring treatment potential: clinical and genetic insights into biotinidase deficiency in six patients: a tertiary care hospital experience. Neurochem J. 2024;18(4):878\u201385. https:\/\/doi.org\/10.1134\/S1819712424700521.","journal-title":"Neurochem J"},{"key":"4513_CR29","doi-asserted-by":"publisher","unstructured":"Wasim M, Khan HN, Tawab A, Habib FE, Iqbal M, Awan FR. High-performance liquid chromatography-based assay optimization for the detection of plasma amino acids for applications in metabolic disorders in developing countries. Sep Sci Plus. 2023;6(11):2300119. https:\/\/doi.org\/10.1002\/sscp.202300119","DOI":"10.1002\/sscp.202300119"},{"key":"4513_CR30","doi-asserted-by":"publisher","first-page":"100011","DOI":"10.1016\/j.rare.2023.100011","volume":"1","author":"M Wasim","year":"2023","unstructured":"Wasim M, Khan HN, Ayesha H, Awan FR. Initiating newborn screening for metabolic disorders in Pakistan: a qualitative study of the early challenges and opportunities. Rare. 2023;1:100011. https:\/\/doi.org\/10.1016\/j.rare.2023.100011.","journal-title":"Rare"},{"key":"4513_CR31","doi-asserted-by":"publisher","unstructured":"Wasim M, Khan HN, Ayesha H, Awan FR. Need and challenges in establishing newborn screening programs for inherited metabolic disorders in developing countries. Adv Biol. 2023;7(7):e2200318. https:\/\/doi.org\/10.1002\/adbi.202200318.","DOI":"10.1002\/adbi.202200318"},{"key":"4513_CR32","doi-asserted-by":"publisher","unstructured":"Wasim M, Khan HN, Ayesha H, Iqbal M, Tawab A, Irfan M, et al. Identification of three novel pathogenic mutations in cystathionine beta-synthase gene of Pakistani intellectually disabled patients. J Pediatr Endocrinol Metab. 2021 https:\/\/doi.org\/10.1515\/jpem-2021-0508.","DOI":"10.1515\/jpem-2021-0508"},{"key":"4513_CR33","doi-asserted-by":"publisher","first-page":"100761","DOI":"10.1016\/j.ymgmr.2021.100761","volume":"27","author":"BP Modi","year":"2021","unstructured":"Modi BP, Khan HN, van der Lee R, Wasim M, Haaxma CA, Richmond PA, et al. Adult GAMT deficiency: a literature review and report of two siblings. Mol Genet Metab Rep. 2021;27:100761. https:\/\/doi.org\/10.1016\/j.ymgmr.2021.100761.","journal-title":"Mol Genet Metab Rep"},{"issue":"5","key":"4513_CR34","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1080\/20473869.2020.1858520","volume":"68","author":"M Wasim","year":"2022","unstructured":"Wasim M, Khan HN, Ayesha H, Tawab A, Habib FE, Asi MR, et al. High levels of blood glutamic acid and ornithine in children with intellectual disability. Int J Dev Disabil. 2022;68(5):609\u201314. https:\/\/doi.org\/10.1080\/20473869.2020.1858520.","journal-title":"Int J Dev Disabilities"},{"issue":"3","key":"4513_CR35","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1080\/20473869.2018.1533084","volume":"66","author":"M Wasim","year":"2020","unstructured":"Wasim M, Khan HN, Ayesha H, Awan FR. Biochemical screening of intellectually disabled and healthy children in Punjab, Pakistan: differences in liver function test and lipid profiles. Int J Dev Disabil. 2020;66(3):190\u201395. https:\/\/doi.org\/10.1080\/20473869.2018.1533084.","journal-title":"Int J Dev Disabilities"},{"key":"4513_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fneur.2019.00762","volume":"10","author":"M Wasim","year":"2019","unstructured":"Wasim M, Khan HN, Ayesha H, Goorden SMI, Vaz FM, van Karnebeek CDM, et al. Biochemical screening of intellectually disabled patients: a stepping stone to initiate a newborn screening program in Pakistan. Front Neurol. 2019;10:10. https:\/\/doi.org\/10.3389\/fneur.2019.00762.","journal-title":"Front Neurol"},{"issue":"1\u20132","key":"4513_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10528-017-9825-6","volume":"56","author":"M Wasim","year":"2018","unstructured":"Wasim M, Awan FR, Khan HN, Tawab A, Iqbal M, Ayesha H. Aminoacidopathies: prevalence, etiology, screening, and treatment options. Biochem Genet. 2018;56(1\u20132):7\u201321. https:\/\/doi.org\/10.1007\/s10528-017-9825-6.","journal-title":"Biochem Genet"},{"issue":"2","key":"4513_CR38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1615\/CritRevEukaryotGeneExpr.2018023073","volume":"28","author":"M Wasim","year":"2018","unstructured":"Wasim M, Awan FR, Khan HN, Ayesha H. An overview of traditional and novel therapeutic options for the management of phenylketonuria. Crit Rev Eukaryot Gene Expr. 2018;28(2):177\u201385. https:\/\/doi.org\/10.1615\/CritRevEukaryotGeneExpr.2018023073.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"6","key":"4513_CR39","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1007\/s11033-018-4426-y","volume":"45","author":"HN Khan","year":"2018","unstructured":"Khan HN, Wasim M, Ayesha H, Awan FR. Molecular genetic diagnosis of Wilson disease by ARMS-PCR in a Pakistani family. Mol Biol Rep. 2018;45(6):2585\u201391. https:\/\/doi.org\/10.1007\/s11033-018-4426-y.","journal-title":"Mol Biol Rep"},{"issue":"3","key":"4513_CR40","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/proteomes12030025","volume":"12","author":"R Vitorino","year":"2024","unstructured":"Vitorino R. Transforming clinical research: the power of high-throughput omics integration. Proteomes. 2024;12(3):12. https:\/\/doi.org\/10.3390\/proteomes12030025.","journal-title":"Proteomes"},{"key":"4513_CR41","doi-asserted-by":"publisher","first-page":"911861","DOI":"10.3389\/fmed.2022.911861","volume":"9","author":"X Dai","year":"2022","unstructured":"Dai X, Shen L. Advances and trends in omics technology development. Front Med (Lausanne). 2022;9:911861. https:\/\/doi.org\/10.3389\/fmed.2022.911861.","journal-title":"Front Med"},{"issue":"5","key":"4513_CR42","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/S0022-3476(75)80349-0","volume":"86","author":"JH Dussault","year":"1975","unstructured":"Dussault JH, Coulombe P, Laberge C, Letarte J, Guyda H, Khoury K. Preliminary report on a mass screening program for neonatal hypothyroidism. J Pediatr. 1975;86(5):670\u201374. https:\/\/doi.org\/10.1016\/S0022-3476(75)80349-0.","journal-title":"J Pediatrics"},{"issue":"8","key":"4513_CR43","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.3390\/molecules27082411","volume":"27","author":"A-N Neagu","year":"2022","unstructured":"Neagu A-N, Jayathirtha M, Baxter E, Donnelly M, Petre BA, Darie CC. Applications of tandem mass spectrometry (MS\/MS) in protein analysis for biomedical research. Molecules. 2022;27(8):2411. https:\/\/doi.org\/10.3390\/molecules27082411.","journal-title":"Molecules"},{"issue":"1","key":"4513_CR44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jgg.2021.08.008","volume":"49","author":"C Hao","year":"2022","unstructured":"Hao C, Guo R, Hu X, Qi Z, Guo Q, Liu X, et al. Newborn screening with targeted sequencing: a multicenter investigation and a pilot clinical study in China. J Genet Genomics. 2022;49(1):13\u201319. https:\/\/doi.org\/10.1016\/j.jgg.2021.08.008.","journal-title":"J Genet Genomics"},{"key":"4513_CR45","doi-asserted-by":"publisher","unstructured":"Kampmann M, Bassik MC, Weissman JS. Integrated platform for genome-wide screening and construction of high-density genetic interaction maps in mammalian cells. Proc Natl Acad Sci USA. 2013;110(25):E2317\u2013E2326. https:\/\/doi.org\/10.1073\/pnas.1307002110.","DOI":"10.1073\/pnas.1307002110"},{"issue":"8","key":"4513_CR46","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1053\/j.semperi.2015.09.010","volume":"39","author":"L Francescatto","year":"2015","unstructured":"Francescatto L, Katsanis N. Newborn screening and the era of medical genomics. Semin Perinatol. 2015;39(8):617\u201322. https:\/\/doi.org\/10.1053\/j.semperi.2015.09.010.","journal-title":"Semin Perinatol"},{"key":"4513_CR47","doi-asserted-by":"crossref","unstructured":"Zack M, Stupichev DN, Moore AJ, Slobodchikov ID, Sokolov DG, Trifonov IF, et al. Artificial intelligence and multi-omics in pharmacogenomics: a new era of precision medicine. Mayo Clin Proc Digit Health. 2025;3:100246","DOI":"10.1016\/j.mcpdig.2025.100246"},{"issue":"1","key":"4513_CR48","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev-biodatasci-102523-103801","volume":"7","author":"Y Nam","year":"2024","unstructured":"Nam Y, Kim J, Jung SH, Woerner J, Suh EH, Lee DG, et al. Harnessing artificial intelligence in multimodal omics data integration: paving the path for the next frontier in precision medicine. Annu Rev Biomed Data Sci. 2024;7(1):225\u201350. https:\/\/doi.org\/10.1146\/annurev-biodatasci-102523-103801.","journal-title":"Annu Rev Biomed Data Sci"},{"key":"4513_CR49","doi-asserted-by":"publisher","unstructured":"Sibilio P, Smaele ED, Paci P, Conte F. Integrating multi-omics data: methods and applications in human complex diseases. Biotechnol Rep. 2025;48:e00938. https:\/\/doi.org\/10.1016\/j.btre.2025.e00938.","DOI":"10.1016\/j.btre.2025.e00938"},{"key":"4513_CR50","doi-asserted-by":"publisher","first-page":"100215","DOI":"10.1016\/j.jcoa.2025.100215","volume":"7","author":"H-M Xiao","year":"2025","unstructured":"Xiao H-M, Temerdashev A, An N, Zhu Q-F, Feng Y-Q. Advancing clinical liquid chromatography-mass spectrometry analysis: rational design and optimization of derivatization techniques for enhanced sensitivity and throughput. J Chromatogr Open. 2025;7:100215. https:\/\/doi.org\/10.1016\/j.jcoa.2025.100215.","journal-title":"J Chromatogr Open"},{"issue":"1","key":"4513_CR51","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12920-023-01483-1","volume":"16","author":"X He","year":"2023","unstructured":"He X, Kuang J, Lai J, Huang J, Wang Y, Lan G, et al. A retrospective analysis of MS\/MS screening for IEM in high-risk areas. BMC Med Genomics. 2023;16(1):57. https:\/\/doi.org\/10.1186\/s12920-023-01483-1.","journal-title":"BMC Med Genomics"},{"key":"4513_CR52","doi-asserted-by":"publisher","unstructured":"Kononets V, Zharmakhanova G, Balmagambetova S, Syrlybayeva L, Berdesheva G, Zhussupova Z, et al. Tandem mass spectrometry in screening for inborn errors of metabolism: comprehensive bibliometric analysis. Front Pediatr. 2025;13:- 2025. https:\/\/doi.org\/10.3389\/fped.2025.1463294.","DOI":"10.3389\/fped.2025.1463294"},{"key":"4513_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trac.2011.08.009","volume":"32","author":"JF Xiao","year":"2012","unstructured":"Xiao JF, Zhou B, Ressom HW. Metabolite identification and quantitation in LC-MS\/MS-based metabolomics. TrAC Trends Anal Chem. 2012;32:1\u201314. https:\/\/doi.org\/10.1016\/j.trac.2011.08.009.","journal-title":"TrAC Trends Analytical Chem"},{"key":"4513_CR54","doi-asserted-by":"publisher","first-page":"124256","DOI":"10.1016\/j.jchromb.2024.124256","volume":"1245","author":"X Li","year":"2024","unstructured":"Li X, Tian S, Riezman I, Qin Y, Riezman H, Feng S. A sensitive, expandable AQC-based LC-MS\/MS method to measure amino metabolites and sphingolipids in cell and serum samples. J Chromatogr B Analyt Technol Biomed Life Sci. 2024;1245:124256. https:\/\/doi.org\/10.1016\/j.jchromb.2024.124256.","journal-title":"J Chromatogr B"},{"issue":"1","key":"4513_CR55","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/s41598-017-01435-7","volume":"7","author":"J Wang","year":"2017","unstructured":"Wang J, Zhou L, Lei H, Hao F, Liu X, Wang Y, et al. Simultaneous quantification of amino metabolites in multiple metabolic pathways using ultra-high performance liquid chromatography with tandem-mass spectrometry. Sci Rep. 2017;7(1):1423. https:\/\/doi.org\/10.1038\/s41598-017-01435-7.","journal-title":"Sci Rep"},{"key":"4513_CR56","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-1-4939-2377-9_13","volume":"1277","author":"AH Emwas","year":"2015","unstructured":"Emwas AH. The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research. Methods Mol Biol. 2015;1277:161\u201393.","journal-title":"Methods Mol Biol"},{"issue":"18","key":"4513_CR57","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/ijms25189880","volume":"25","author":"A Son","year":"2024","unstructured":"Son A, Kim W, Park J, Park Y, Lee W, Lee S, et al. Mass spectrometry advancements and applications for biomarker discovery, diagnostic innovations, and personalized medicine. Int J Mol Sci. 2024;25(18):25. https:\/\/doi.org\/10.3390\/ijms25189880.","journal-title":"IJMS"},{"issue":"1","key":"4513_CR58","doi-asserted-by":"publisher","first-page":"100887","DOI":"10.1016\/j.mcpro.2024.100887","volume":"24","author":"S Wu","year":"2025","unstructured":"Wu S, Zhang S, Liu C-M, Fernie AR, Yan S. Recent advances in Mass spectrometry-based protein interactome studies. Mol Cell Proteomics. 2025;24(1):100887. https:\/\/doi.org\/10.1016\/j.mcpro.2024.100887.","journal-title":"Mol Cellular Proteomics"},{"issue":"1","key":"4513_CR59","doi-asserted-by":"publisher","first-page":"101604","DOI":"10.1016\/j.gim.2025.101604","volume":"28","author":"IT Khoja","year":"2026","unstructured":"Khoja IT, Peck DS, Gavrilov DK, McPheron MA, Oglesbee D, Pino GB, et al. Reduction of false-positive results with biochemical second-tier testing for newborn screening of Pompe disease. Genet Med. 2026;28(1):101604. https:\/\/doi.org\/10.1016\/j.gim.2025.101604.","journal-title":"Genet Med"},{"issue":"2","key":"4513_CR60","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/ijns6020032","volume":"6","author":"LD Smith","year":"2020","unstructured":"Smith LD, Bainbridge MN, Parad RB, Bhattacharjee A. Second tier molecular genetic testing in newborn screening for Pompe disease: landscape and challenges. Int J Neonatal Screen. 2020;6(2):6. https:\/\/doi.org\/10.3390\/ijns6020032.","journal-title":"IJNS"},{"issue":"3","key":"4513_CR61","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/ehf2.12176","volume":"4","author":"A Yoshihisa","year":"2017","unstructured":"Yoshihisa A, Watanabe S, Yokokawa T, Misaka T, Sato T, Suzuki S, et al. Associations between acylcarnitine to free carnitine ratio and adverse prognosis in heart failure patients with reduced or preserved ejection fraction. ESC Heart Fail. 2017;4(3):360\u201364. https:\/\/doi.org\/10.1002\/ehf2.12176.","journal-title":"ESC Heart Fail"},{"issue":"2","key":"4513_CR62","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41436-020-00990-1","volume":"23","author":"MJ Miller","year":"2021","unstructured":"Miller MJ, Cusmano-Ozog K, Oglesbee D, Young S. Laboratory analysis of acylcarnitines, 2020 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021;23(2):249\u201358. https:\/\/doi.org\/10.1038\/s41436-020-00990-1.","journal-title":"Genet Med"},{"issue":"6","key":"4513_CR63","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/children10060999","volume":"10","author":"A S\u00e9assau","year":"2023","unstructured":"S\u00e9assau A, Munos P, Gire C, Tosello B, Carchon I. Neonatal care unit interventions on preterm development. Children (Basel). 2023;10(6):10. https:\/\/doi.org\/10.3390\/children10060999.","journal-title":"Children (Basel)"},{"key":"4513_CR64","doi-asserted-by":"publisher","unstructured":"Nist MD, Robinson A, Harrison TM, Pickler RH. An integrative review of clinician-administered comforting touch interventions and acute stress responses of preterm infants. J Pediatr Nurs. 2022;67:e113\u201322. https:\/\/doi.org\/10.1016\/j.pedn.2022.08.020.","DOI":"10.1016\/j.pedn.2022.08.020"},{"issue":"2","key":"4513_CR65","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10880-022-09902-8","volume":"30","author":"KH Ginsberg","year":"2023","unstructured":"Ginsberg KH, Alsweiler J, Alyami M, Serlachius A. Mindfulness and relaxation-based interventions to reduce parental stress, anxiety and\/or depressive symptoms in the neonatal intensive care unit: a systematic review. J Clin Psychol Med Settings. 2023;30(2):387\u2013402. https:\/\/doi.org\/10.1007\/s10880-022-09902-8.","journal-title":"J Clin Psychol Med Settings"},{"key":"4513_CR66","doi-asserted-by":"publisher","unstructured":"Wang X, Liu Y, Jiang C, Huang Z, Yan H, Wong SH, et al. TidyMass2: advancing LC-MS untargeted metabolomics through metabolite origin inference and metabolic feature-based functional module analysis. Nat Commun. 2026;17(1):1755. https:\/\/doi.org\/10.1038\/s41467-026-68464-7.","DOI":"10.1038\/s41467-026-68464-7"},{"issue":"1","key":"4513_CR67","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00441-023-03816-z","volume":"394","author":"S Ng","year":"2023","unstructured":"Ng S, Masarone S, Watson D, Barnes MR. The benefits and pitfalls of machine learning for biomarker discovery. Cell Tissue Res. 2023;394(1):17\u201331. https:\/\/doi.org\/10.1007\/s00441-023-03816-z.","journal-title":"Cell Tissue Res"},{"issue":"2","key":"4513_CR68","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1042\/ETLS20243003","volume":"8","author":"H Javaid","year":"2025","unstructured":"Javaid H, Petrescu CC, Schmunk LJ, Monahan JM, O\u2019Reilly P, Garg M, et al. The impact of artificial intelligence on biomarker discovery. Emerg Top Life Sci. 2025;8(2):89\u2013105. https:\/\/doi.org\/10.1042\/ETLS20243003.","journal-title":"Emerging Top Life Sci"},{"key":"4513_CR69","doi-asserted-by":"publisher","first-page":"117852","DOI":"10.1016\/j.trac.2024.117852","volume":"178","author":"J Chi","year":"2024","unstructured":"Chi J, Shu J, Li M, Mudappathi R, Jin Y, Lewis F, et al. Artificial intelligence in metabolomics: a current review. TrAC Trends Anal Chem. 2024;178:117852. https:\/\/doi.org\/10.1016\/j.trac.2024.117852.","journal-title":"TrAC Trends Analytical Chem"},{"issue":"1","key":"4513_CR70","doi-asserted-by":"publisher","first-page":"7136","DOI":"10.1038\/s41467-024-51433-3","volume":"15","author":"Y Deng","year":"2024","unstructured":"Deng Y, Yao Y, Wang Y, Yu T, Cai W, Zhou D, et al. An end-to-end deep learning method for mass spectrometry data analysis to reveal disease-specific metabolic profiles. Nat Commun. 2024;15(1):7136. https:\/\/doi.org\/10.1038\/s41467-024-51433-3.","journal-title":"Nat Commun"},{"issue":"1","key":"4513_CR71","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/metabo8010004","volume":"8","author":"M Cuperlovic-Culf","year":"2018","unstructured":"Cuperlovic-Culf M. Machine learning methods for analysis of metabolic data and metabolic pathway modeling. Metabolites. 2018;8(1):8. https:\/\/doi.org\/10.3390\/metabo8010004.","journal-title":"Metabolites"},{"issue":"6","key":"4513_CR72","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/cells13060504","volume":"13","author":"P Brlek","year":"2024","unstructured":"Brlek P, Buli\u0107 L, Bra\u010di\u0107 M, Proji\u0107 P, \u0160karo V, Shah N, et al. Implementing whole genome sequencing (WGS) in clinical practice: advantages, challenges, and future perspectives. Cells. 2024;13(6):13. https:\/\/doi.org\/10.3390\/cells13060504.","journal-title":"Cells"},{"issue":"1","key":"4513_CR73","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12920-024-01795-w","volume":"17","author":"FO Bagger","year":"2024","unstructured":"Bagger FO, Borgwardt L, Jespersen AS, Hansen AR, Bertelsen B, Kodama M, et al. Whole genome sequencing in clinical practice. BMC Med Genomics. 2024;17(1):39. https:\/\/doi.org\/10.1186\/s12920-024-01795-w.","journal-title":"BMC Med Genomics"},{"issue":"1","key":"4513_CR74","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3390\/ijms26010372","volume":"26","author":"Y Lu","year":"2025","unstructured":"Lu Y, Li M, Gao Z, Ma H, Chong Y, Hong J, et al. Advances in whole genome sequencing: methods, tools, and applications in population genomics. Int J Mol Sci. 2025;26(1):372. https:\/\/doi.org\/10.3390\/ijms26010372.","journal-title":"IJMS"},{"issue":"11","key":"4513_CR75","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1038\/s41416-024-02890-6","volume":"131","author":"EYL Leung","year":"2024","unstructured":"Leung EYL, Robbins HL, Zaman S, Lal N, Morton D, Dew L, et al. The potential clinical utility of whole genome sequencing for patients with cancer: evaluation of a regional implementation of the 100, 000 Genomes Project. Br J Cancer. 2024;131(11):1805\u201313. https:\/\/doi.org\/10.1038\/s41416-024-02890-6.","journal-title":"Br J Cancer"},{"issue":"1","key":"4513_CR76","doi-asserted-by":"publisher","first-page":"100055","DOI":"10.1016\/j.engmed.2025.100055","volume":"2","author":"Q Yang","year":"2025","unstructured":"Yang Q, Duan S, Huang Y, Liu C, Wang M, He G. The large-scale whole-genome sequencing era expedited medical discovery and clinical translation. EngMedicine. 2025;2(1):100055. https:\/\/doi.org\/10.1016\/j.engmed.2025.100055.","journal-title":"EngMedicine"},{"issue":"1","key":"4513_CR77","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41525-022-00295-z","volume":"7","author":"CA Austin-Tse","year":"2022","unstructured":"Austin-Tse CA, Jobanputra V, Perry DL, Bick D, Taft RJ, Venner E, et al. Best practices for the interpretation and reporting of clinical whole genome sequencing. NPJ Genom Med. 2022;7(1):27. https:\/\/doi.org\/10.1038\/s41525-022-00295-z.","journal-title":"npj Genom. Med"},{"issue":"10","key":"4513_CR78","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1016\/j.ajhg.2024.08.011","volume":"111","author":"HS Smith","year":"2024","unstructured":"Smith HS, Zettler B, Genetti CA, Hickingbotham MR, Coleman TF, Lebo M, et al. The BabySeq project: a clinical trial of genome sequencing in a diverse cohort of infants. Am J Hum Genet. 2024;111(10):2094\u2013106. https:\/\/doi.org\/10.1016\/j.ajhg.2024.08.011.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"4513_CR79","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41587-025-02595-y","volume":"43","author":"C Sheridan","year":"2025","unstructured":"Sheridan C. Baby genomics: newborn sequencing starts to fulfill its promise. Nat Biotechnol. 2025;43(3):290\u201392. https:\/\/doi.org\/10.1038\/s41587-025-02595-y.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"4513_CR80","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/cge.14760","volume":"108","author":"C Lucca","year":"2025","unstructured":"Lucca C, Rosina E, Pezzani L, Piazzolla D, Spaccini L, Scatigno A, et al. First-tier versus last-tier trio whole-genome sequencing for the diagnosis of pediatric-onset rare diseases. Clin Genet. 2025;108(4):412\u201321. https:\/\/doi.org\/10.1111\/cge.14760.","journal-title":"Clin Genet"},{"issue":"4","key":"4513_CR81","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/s41390-025-03874-9","volume":"97","author":"DK Stevenson","year":"2025","unstructured":"Stevenson DK, Wong RJ, Reiss JD, Shaw GM, Aghaeepour N, Mahzarnia A, et al. Advancing neonatal health: the promise and challenges of universal genome sequencing in newborn screening. Pediatr Res. 2025;97(4):1258\u201360. https:\/\/doi.org\/10.1038\/s41390-025-03874-9.","journal-title":"Pediatr Res"},{"key":"4513_CR82","doi-asserted-by":"publisher","unstructured":"Balciuniene J, Liu R, Bean L, Guo F, Nallamilli BRR, Guruju N, et al. At-risk genomic findings for pediatric-onset disorders from genome sequencing vs medically actionable gene panel in proactive screening of newborns and children. JAMA Netw Open. 2023;6(7):e2326445. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.26445.","DOI":"10.1001\/jamanetworkopen.2023.26445"},{"issue":"7","key":"4513_CR83","doi-asserted-by":"publisher","first-page":"994","DOI":"10.7326\/M21-4109","volume":"175","author":"W Burke","year":"2022","unstructured":"Burke W, Parens E, Chung WK, Berger SM, Appelbaum PS. The challenge of genetic variants of uncertain clinical significance: a narrative review. Ann Intern Med. 2022;175(7):994\u20131000. https:\/\/doi.org\/10.7326\/M21-4109.","journal-title":"Ann Intern Med"},{"issue":"1","key":"4513_CR84","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41698-023-00420-w","volume":"7","author":"A Johnson","year":"2023","unstructured":"Johnson A, Ng PK-S, Kahle M, Castillo J, Amador B, Wang Y, et al. Actionability classification of variants of unknown significance correlates with functional effect. NPJ Precis Oncol. 2023;7(1):67. https:\/\/doi.org\/10.1038\/s41698-023-00420-w.","journal-title":"Npj Precis Onc"},{"issue":"7","key":"4513_CR85","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1038\/s41588-025-02212-3","volume":"57","author":"IS Forrest","year":"2025","unstructured":"Forrest IS, Huang K-L, Eggington JM, Chung WK, Jordan DM, Do R. Using large-scale population-based data to improve disease risk assessment of clinical variants. Nat Genet. 2025;57(7):1588\u201397. https:\/\/doi.org\/10.1038\/s41588-025-02212-3.","journal-title":"Nat Genet"},{"issue":"8","key":"4513_CR86","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/j.ajhg.2025.06.012","volume":"112","author":"V Bhat","year":"2025","unstructured":"Bhat V, Yu T, Brown L, Pejaver V, Lebo M, Harrison S, et al. Extracting and calibrating evidence of variant pathogenicity from population biobank data. Am J Hum Genet. 2025;112(8):1805\u201317. https:\/\/doi.org\/10.1016\/j.ajhg.2025.06.012.","journal-title":"Am J Hum Genet"},{"issue":"8","key":"4513_CR87","doi-asserted-by":"publisher","first-page":"101454","DOI":"10.1016\/j.gim.2025.101454","volume":"27","author":"K Lee","year":"2025","unstructured":"Lee K, Abul-Husn NS, Amendola LM, Brothers KB, Chung WK, Gollob MH, et al. ACMG SF v3.3 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2025;27(8):101454. https:\/\/doi.org\/10.1016\/j.gim.2025.101454.","journal-title":"Genet Med"},{"issue":"8","key":"4513_CR88","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/s41436-021-01171-4","volume":"23","author":"DT Miller","year":"2021","unstructured":"Miller DT, Lee K, Gordon AS, Amendola LM, Adelman K, Bale SJ, et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021;23(8):1391\u201398. https:\/\/doi.org\/10.1038\/s41436-021-01171-4.","journal-title":"Genet Med"},{"key":"4513_CR89","doi-asserted-by":"publisher","unstructured":"Gold NB, Strong A, Somanchi H, Gold J. Are inherited metabolic disorders more common and less predictable than we thought? J Inherit Metab Dis. 2025;48(6):e70094. https:\/\/doi.org\/10.1002\/jimd.70094.","DOI":"10.1002\/jimd.70094"},{"key":"4513_CR90","doi-asserted-by":"publisher","first-page":"105086","DOI":"10.1016\/j.ejmg.2026.105086","volume":"82","author":"A Chebly","year":"2026","unstructured":"Chebly A, Shamieh SE. Genotype before phenotype? Reversing the diagnostic odyssey in genomic medicine. Eur J Med Genet. 2026;82:105086. https:\/\/doi.org\/10.1016\/j.ejmg.2026.105086.","journal-title":"Eur J Med Genet"},{"key":"4513_CR91","doi-asserted-by":"publisher","first-page":"1564032","DOI":"10.3389\/fpsyg.2025.1564032","volume":"16","author":"AL S\u00e9bert","year":"2026","unstructured":"S\u00e9bert AL, Gargiulo M, Lonlay PD, Arnoux JB, Vaiman D, Bensimon C, et al. Psychosocial issues of neonatal screening in the context of its major expansion: a scoping review. Front Psychol. 2026;16:1564032. https:\/\/doi.org\/10.3389\/fpsyg.2025.1564032.","journal-title":"Front Psychol"},{"issue":"3","key":"4513_CR92","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3325\/cmj.2024.65.261","volume":"65","author":"N Shah","year":"2024","unstructured":"Shah N, Brlek P, Buli\u0107 L, Brenner E, \u0160karo V, Skelin A, et al. Genomic sequencing for newborn screening: current perspectives and challenges. Croat Med J. 2024;65(3):261\u201368. https:\/\/doi.org\/10.3325\/cmj.2024.65.261.","journal-title":"Croat Med J"},{"key":"4513_CR93","doi-asserted-by":"publisher","unstructured":"Freeman K, Taylor D, Dinnes J, Clark CCA, Kander I, Scandrett K, et al. Challenges in evaluating whole genome sequencing for newborn screening: series of systematic reviews and roadmap for evidence generation for policy advisers. BMJ Med. 2025;4(1):e001726. https:\/\/doi.org\/10.1136\/bmjmed-2025-001726.","DOI":"10.1136\/bmjmed-2025-001726"},{"issue":"9","key":"4513_CR94","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/s41588-018-0192-y","volume":"50","author":"SE Castel","year":"2018","unstructured":"Castel SE, Cervera A, Mohammadi P, Aguet F, Reverter F, Wolman A, et al. Modified penetrance of coding variants by cis-regulatory variation contributes to disease risk. Nat Genet. 2018;50(9):1327\u201334. https:\/\/doi.org\/10.1038\/s41588-018-0192-y.","journal-title":"Nat Genet"},{"issue":"1","key":"4513_CR95","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1038\/s41467-020-17374-3","volume":"11","author":"AC Fahed","year":"2020","unstructured":"Fahed AC, Wang M, Homburger JR, Patel AP, Bick AG, Neben CL, et al. Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions. Nat Commun. 2020;11(1):3635. https:\/\/doi.org\/10.1038\/s41467-020-17374-3.","journal-title":"Nat Commun"},{"key":"4513_CR96","doi-asserted-by":"publisher","unstructured":"Roberts E, Flaum N, Evans DG. Clinical implementation of polygenic risk scores. Eur J Hum Genet. 2025. https:\/\/doi.org\/10.1038\/s41431-025-01931-9.","DOI":"10.1038\/s41431-025-01931-9"},{"issue":"3","key":"4513_CR97","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41576-025-00900-8","volume":"27","author":"IJ Kullo","year":"2026","unstructured":"Kullo IJ. Clinical use of polygenic risk scores: current status, barriers and future directions. Nat Rev Genet. 2026;27(3):246\u201363. https:\/\/doi.org\/10.1038\/s41576-025-00900-8.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"4513_CR98","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13073-020-00742-5","volume":"12","author":"CM Lewis","year":"2020","unstructured":"Lewis CM, Vassos E. Polygenic risk scores: from research tools to clinical instruments. Genome Med. 2020;12(1):44. https:\/\/doi.org\/10.1186\/s13073-020-00742-5.","journal-title":"Genome Med"},{"issue":"4","key":"4513_CR99","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41588-019-0379-x","volume":"51","author":"AR Martin","year":"2019","unstructured":"Martin AR, Kanai M, Kamatani Y, Okada Y, Neale BM, Daly MJ. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat Genet. 2019;51(4):584\u201391. https:\/\/doi.org\/10.1038\/s41588-019-0379-x.","journal-title":"Nat Genet"},{"issue":"7","key":"4513_CR100","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.ajhg.2025.05.001","volume":"112","author":"R Peters","year":"2025","unstructured":"Peters R, Best S, Lynch F, Vears DF, Downie L, Archibald AD, et al. Public preferences for the value and implementation of genomic newborn screening: insights from two discrete choice experiments in Australia. Am J Hum Genet. 2025;112(7):1515\u201327. https:\/\/doi.org\/10.1016\/j.ajhg.2025.05.001.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"4513_CR101","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/ijns11010001","volume":"11","author":"A Veldman","year":"2024","unstructured":"Veldman A, Sikkema-Raddatz B, Derks TGJ, van Karnebeek CDM, Kiewiet MBG, Mulder MF, et al. Newborn screening by DNA-First: systematic evaluation of the eligibility of inherited metabolic disorders based on treatability. Int J Neonatal Screen. 2024;11(1):11. https:\/\/doi.org\/10.3390\/ijns11010001.","journal-title":"IJNS"},{"issue":"1","key":"4513_CR102","first-page":"141","volume":"19","author":"DB Bailey Jr","year":"2009","unstructured":"Bailey DB Jr. The blurred distinction between treatable and untreatable conditions in newborn screening. Health Matrix Clevel. 2009;19(1):141\u201353.","journal-title":"Health Matrix Clevel"},{"issue":"1","key":"4513_CR103","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cmet.2015.11.012","volume":"23","author":"CA Argmann","year":"2016","unstructured":"Argmann CA, Houten SM, Zhu J, Schadt EE. A next generation multiscale view of inborn errors of metabolism. Cell MetabCell Metab. 2016;23(1):13\u201326. https:\/\/doi.org\/10.1016\/j.cmet.2015.11.012.","journal-title":"Cell MetabCell Metab"},{"issue":"5","key":"4513_CR104","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s10545-018-0209-9","volume":"41","author":"JM Saudubray","year":"2018","unstructured":"Saudubray JM, Mochel F. The phenotype of adult versus pediatric patients with inborn errors of metabolism. J Inherit Metab Dis. 2018;41(5):753\u201356. https:\/\/doi.org\/10.1007\/s10545-018-0209-9.","journal-title":"J Inher Metab Disea"},{"key":"4513_CR105","doi-asserted-by":"publisher","unstructured":"Fasham J, McPhater A, Whittington R, Pagnamenta AT, Hall TS, Berry IR, et al. Uncovering apparent incomplete penetrance of TSC1\/TSC2 variants: insights from multiple population cohorts and implications for newborn screening. Eur J Hum Genet. 2026. https:\/\/doi.org\/10.1038\/s41431-026-02107-9.","DOI":"10.1038\/s41431-026-02107-9"},{"key":"4513_CR106","doi-asserted-by":"publisher","first-page":"100666","DOI":"10.1016\/j.cosrev.2024.100666","volume":"54","author":"Z Amiri","year":"2024","unstructured":"Amiri Z, Heidari A, Jafari N, Hosseinzadeh M. Deep study on autonomous learning techniques for complex pattern recognition in interconnected information systems. Comput Sci Rev. 2024;54:100666. https:\/\/doi.org\/10.1016\/j.cosrev.2024.100666.","journal-title":"Comput Sci Rev"},{"issue":"4","key":"4513_CR107","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/risa.14307","volume":"45","author":"K St\u00f8dle","year":"2025","unstructured":"St\u00f8dle K, Flage R, Guikema S, Aven T. Artificial intelligence for risk analysis\u2014A risk characterization perspective on advances, opportunities, and limitations. Risk Anal. 2025;45(4):738\u201351. https:\/\/doi.org\/10.1111\/risa.14307.","journal-title":"Risk Anal"},{"issue":"6","key":"4513_CR108","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/cimb47060470","volume":"47","author":"K Athanasopoulou","year":"2025","unstructured":"Athanasopoulou K, Michalopoulou VI, Scorilas A, Adamopoulos PG. Integrating artificial intelligence in next-generation sequencing: advances, challenges, and future directions. Curr Issues Mol Biol. 2025;47(6):47. https:\/\/doi.org\/10.3390\/cimb47060470.","journal-title":"CIMB"},{"issue":"7883","key":"4513_CR109","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41586-021-04043-8","volume":"599","author":"J Frazer","year":"2021","unstructured":"Frazer J, Notin P, Dias M, Gomez A, Min JK, Brock K, et al. Disease variant prediction with deep generative models of evolutionary data. Nature. 2021;599(7883):91\u201395. https:\/\/doi.org\/10.1038\/s41586-021-04043-8.","journal-title":"Nature"},{"issue":"3","key":"4513_CR110","doi-asserted-by":"publisher","first-page":"111036","DOI":"10.1016\/j.ygeno.2025.111036","volume":"117","author":"R Radjasandirane","year":"2025","unstructured":"Radjasandirane R, Diharce J, Gelly J-C, de Brevern AG. Insights for variant clinical interpretation based on a benchmark of 65 variant effect predictors. Genomics. 2025;117(3):111036. https:\/\/doi.org\/10.1016\/j.ygeno.2025.111036.","journal-title":"Genomics"},{"issue":"5","key":"4513_CR111","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/bib\/bbaf545","volume":"26","author":"M Costa","year":"2025","unstructured":"Costa M, Garc\u00eda SA, Le\u00f3n A, Pastor O. The promises and pitfalls of automated variant interpretation: a comprehensive review. Brief Bioinform. 2025;26(5):26. https:\/\/doi.org\/10.1093\/bib\/bbaf545.","journal-title":"Briefings Bioinf"},{"key":"4513_CR112","doi-asserted-by":"publisher","first-page":"109808","DOI":"10.1016\/j.compbiomed.2025.109808","volume":"188","author":"B Clay","year":"2025","unstructured":"Clay B, Bergman HI, Salim S, Pergola G, Shalhoub J, Davies AH. Natural language processing techniques applied to the electronic health record in clinical research and practice\u2014an introduction to methodologies. Comput Biol Med. 2025;188:109808. https:\/\/doi.org\/10.1016\/j.compbiomed.2025.109808.","journal-title":"Comput Biol Med"},{"issue":"1","key":"4513_CR113","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41746-025-01527-z","volume":"8","author":"R Shankar","year":"2025","unstructured":"Shankar R, Bundele A, Mukhopadhyay A. Natural language processing of electronic health records for early detection of cognitive decline: a systematic review. NPJ Digit Med. 2025;8(1):133. https:\/\/doi.org\/10.1038\/s41746-025-01527-z.","journal-title":"NPJ Digit Med"},{"issue":"1","key":"4513_CR114","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41746-022-00742-2","volume":"5","author":"X Yang","year":"2022","unstructured":"Yang X, Chen A, PourNejatian N, Shin HC, Smith KE, Parisien C, et al. A large language model for electronic health records. NPJ Digit Med. 2022;5(1):194. https:\/\/doi.org\/10.1038\/s41746-022-00742-2.","journal-title":"NPJ Digit Med"},{"issue":"2","key":"4513_CR115","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/jamia\/ocaf176","volume":"33","author":"L Liu","year":"2026","unstructured":"Liu L, Blake V, Barman M, Gallego B, Churches T, Kennedy G, et al. Using natural language processing to extract information from clinical text in electronic medical records for populating clinical registries: a systematic review. J Am Med Inform Assoc. 2026;33(2):484\u201399. https:\/\/doi.org\/10.1093\/jamia\/ocaf176.","journal-title":"J Am Med Inf Assoc"},{"issue":"8","key":"4513_CR116","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s42256-022-00516-1","volume":"4","author":"W Liang","year":"2022","unstructured":"Liang W, Tadesse GA, Ho D, Fei-Fei L, Zaharia M, Zhang C, et al. Advances, challenges and opportunities in creating data for trustworthy AI. Nat Mach Intell. 2022;4(8):669\u201377. https:\/\/doi.org\/10.1038\/s42256-022-00516-1.","journal-title":"Nat Mach Intell"},{"issue":"1","key":"4513_CR117","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s44267-024-00065-8","volume":"2","author":"X Tu","year":"2024","unstructured":"Tu X, He Z, Huang Y, Zhang Z-H, Yang M, Zhao J. An overview of large AI models and their applications. Vis Intell. 2024;2(1):34. https:\/\/doi.org\/10.1007\/s44267-024-00065-8.","journal-title":"Vis Intell"},{"issue":"3","key":"4513_CR118","doi-asserted-by":"publisher","first-page":"100478","DOI":"10.1016\/j.infoandorg.2023.100478","volume":"33","author":"A Arora","year":"2023","unstructured":"Arora A, Barrett M, Lee E, Oborn E, Prince K. Risk and the future of AI: algorithmic bias, data colonialism, and marginalization. Inf Organ. 2023;33(3):100478. https:\/\/doi.org\/10.1016\/j.infoandorg.2023.100478.","journal-title":"Inf Organ"},{"key":"4513_CR119","doi-asserted-by":"publisher","first-page":"1643180","DOI":"10.3389\/fpubh.2025.1643180","volume":"13","author":"J Joseph","year":"2025","unstructured":"Joseph J. Algorithmic bias in public health AI: a silent threat to equity in low-resource settings. Front Public Health. 2025;13:1643180. https:\/\/doi.org\/10.3389\/fpubh.2025.1643180.","journal-title":"Front Public Health"},{"issue":"10","key":"4513_CR120","doi-asserted-by":"publisher","first-page":"100347","DOI":"10.1016\/j.patter.2021.100347","volume":"2","author":"N Norori","year":"2021","unstructured":"Norori N, Hu Q, Aellen FM, Faraci FD, Tzovara A. Addressing bias in big data and AI for health care: a call for open science. Patterns (N Y). 2021;2(10):100347. https:\/\/doi.org\/10.1016\/j.patter.2021.100347.","journal-title":"Patterns (N Y)"},{"key":"4513_CR121","doi-asserted-by":"publisher","unstructured":"Cross JL, Choma MA, Onofrey JA. Bias in medical AI: implications for clinical decision-making. PLoS Digit Health. 2024;3(11):e0000651. https:\/\/doi.org\/10.1371\/journal.pdig.0000651.","DOI":"10.1371\/journal.pdig.0000651"},{"issue":"9","key":"4513_CR122","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3345\/cep.2025.00962","volume":"68","author":"T Park","year":"2025","unstructured":"Park T, Lee IH, Lee SW, Kong SW. Artificial intelligence in pediatric healthcare: current applications, potential, and implementation considerations. Clin Exp Pediatr. 2025;68(9):641\u201351. https:\/\/doi.org\/10.3345\/cep.2025.00962.","journal-title":"Clin Exp Pediatr"},{"issue":"1","key":"4513_CR123","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12920-025-02261-x","volume":"18","author":"Y Xie","year":"2025","unstructured":"Xie Y, Peng G, Tikhonova I, Enns G, Zhao H, Cowan T, et al. Improving newborn screening accuracy through genome sequencing, targeted metabolomics, and machine learning. BMC Med Genomics. 2025;18(1):187. https:\/\/doi.org\/10.1186\/s12920-025-02261-x.","journal-title":"BMC Med Genomics"},{"key":"4513_CR124","doi-asserted-by":"publisher","first-page":"855943","DOI":"10.3389\/fped.2022.855943","volume":"10","author":"M Zhou","year":"2022","unstructured":"Zhou M, Deng L, Huang Y, Xiao Y, Wen J, Liu N, et al. Application of the artificial intelligence algorithm model for screening of inborn errors of metabolism. Front Pediatr. 2022;10:855943. https:\/\/doi.org\/10.3389\/fped.2022.855943.","journal-title":"Front Pediatr"},{"key":"4513_CR125","unstructured":"National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Committee on a Vision for Newborn Screening. Newborn screening in the United States: a vision for sustaining and advancing excellence. Bowman K, Dawson EP, Mullen J, editors. Washington (DC): National Academies Press (US); 2025."},{"issue":"6","key":"4513_CR126","doi-asserted-by":"publisher","first-page":"497","DOI":"10.5582\/bst.2024.01342","volume":"18","author":"K Karako","year":"2024","unstructured":"Karako K, Tang W. Applications of and issues with machine learning in medicine: bridging the gap with explainable AI. Biosci Trends. 2024;18(6):497\u2013504. https:\/\/doi.org\/10.5582\/bst.2024.01342.","journal-title":"BST"},{"issue":"12","key":"4513_CR127","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1038\/s41591-021-01577-2","volume":"27","author":"MK Cho","year":"2021","unstructured":"Cho MK. Rising to the challenge of bias in health care AI. Nat Med. 2021;27(12):2079\u201381. https:\/\/doi.org\/10.1038\/s41591-021-01577-2.","journal-title":"Nat Med"},{"key":"4513_CR128","doi-asserted-by":"publisher","unstructured":"Kelly A, Bhardwaj N, Sainte-Marie TTH, de Ven PV, Melia R, Williams JE, et al. Investigating how clinicians form trust in an AI-based mental health model: qualitative case study. JMIR Hum Factors. 2025;12:e79658. https:\/\/doi.org\/10.2196\/79658.","DOI":"10.2196\/79658"},{"issue":"1","key":"4513_CR129","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12911-025-02944-6","volume":"25","author":"R Alkhanbouli","year":"2025","unstructured":"Alkhanbouli R, Almadhaani HMA, Alhosani F, Simsekler MCE. The role of explainable artificial intelligence in disease prediction: a systematic literature review and future research directions. BMC Med Inform Decis Mak. 2025;25(1):110. https:\/\/doi.org\/10.1186\/s12911-025-02944-6.","journal-title":"BMC Med Inf Decis Mak"},{"key":"4513_CR130","doi-asserted-by":"publisher","unstructured":"Lou P, Zhu Y, Chia N, Kumari R, Yang W, Wang Y, et al. A human-in-the-loop explanation framework for morphologically transparent AI predictions from whole-slide images. NPJ Digit Med. 2026. https:\/\/doi.org\/10.1038\/s41746-026-02741-z.","DOI":"10.1038\/s41746-026-02741-z"},{"key":"4513_CR131","doi-asserted-by":"publisher","first-page":"100133","DOI":"10.1016\/j.jrt.2025.100133","volume":"23","author":"MAR Bak","year":"2025","unstructured":"Bak MAR, Schut MC, Ploem MC. Embedding ethical and legal principles in AI-driven clinical practice: two use cases in laboratory diagnostics. J Responsib Technol. 2025;23:100133. https:\/\/doi.org\/10.1016\/j.jrt.2025.100133.","journal-title":"J Responsib Technol"},{"issue":"1","key":"4513_CR132","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1038\/s41467-025-57216-8","volume":"16","author":"LA Smith","year":"2025","unstructured":"Smith LA, Cahill JA, Lee JH, Graim K. Equitable machine learning counteracts ancestral bias in precision medicine. Nat Commun. 2025;16(1):2144. https:\/\/doi.org\/10.1038\/s41467-025-57216-8.","journal-title":"Nat Commun"},{"issue":"1","key":"4513_CR133","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12687-023-00678-4","volume":"15","author":"S Coghlan","year":"2023","unstructured":"Coghlan S, Gyngell C, Vears DF. Ethics of artificial intelligence in prenatal and pediatric genomic medicine. J Community Genet. 2023;15(1):13\u201324. https:\/\/doi.org\/10.1007\/s12687-023-00678-4.","journal-title":"J Community Genet"},{"issue":"1","key":"4513_CR134","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev-biodatasci-020722-020704","volume":"6","author":"Y Gao","year":"2023","unstructured":"Gao Y, Sharma T, Cui Y. Addressing the challenge of biomedical data inequality: an artificial intelligence perspective. Annu Rev Biomed Data Sci. 2023;6(1):153\u201371. https:\/\/doi.org\/10.1146\/annurev-biodatasci-020722-020704.","journal-title":"Annu Rev Biomed Data Sci"},{"issue":"S1","key":"4513_CR135","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12920-024-02072-6","volume":"18","author":"H Han","year":"2025","unstructured":"Han H. Challenges of reproducible AI in biomedical data science. BMC Med Genomics. 2025;18(S1):8. https:\/\/doi.org\/10.1186\/s12920-024-02072-6.","journal-title":"BMC Med Genomics"},{"issue":"1","key":"4513_CR136","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00701-024-05892-8","volume":"166","author":"O Ciobanu-Caraus","year":"2024","unstructured":"Ciobanu-Caraus O, Aicher A, Kernbach JM, Regli L, Serra C, Staartjes VE. A critical moment in machine learning in medicine: on reproducible and interpretable learning. Acta Neurochir (Wien). 2024;166(1):14. https:\/\/doi.org\/10.1007\/s00701-024-05892-8.","journal-title":"Acta Neurochir (Wien)"},{"issue":"4","key":"4513_CR137","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1001\/jama.2019.20866","volume":"323","author":"AL Beam","year":"2020","unstructured":"Beam AL, Manrai AK, Ghassemi M. Challenges to the reproducibility of machine learning models in health care. JAMA. 2020;323(4):305\u201306. https:\/\/doi.org\/10.1001\/jama.2019.20866.","journal-title":"JAMA"},{"issue":"1","key":"4513_CR138","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41525-025-00480-w","volume":"10","author":"SW Kong","year":"2025","unstructured":"Kong SW, Lee I-H, Collen LV, Field M, Manrai AK, Snapper SB, et al. Discordance between a deep learning model and clinical-grade variant pathogenicity classification in a rare disease cohort. NPJ Genom Med. 2025;10(1):17. https:\/\/doi.org\/10.1038\/s41525-025-00480-w.","journal-title":"npj Genom. Med"},{"issue":"12","key":"4513_CR139","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1242\/dmm.052218","volume":"17","author":"I Molotkov","year":"2024","unstructured":"Molotkov I, Mardis ER, Artomov M. Making sense of missense: challenges and opportunities in variant pathogenicity prediction. Dis Model Mech. 2024;17(12):17. https:\/\/doi.org\/10.1242\/dmm.052218.","journal-title":"Disease Model Mechanisms"},{"key":"4513_CR140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/DJRF1124","volume":"29","author":"K Freeman","year":"2025","unstructured":"Freeman K, Dinnes J, Shinkins B, Clark C, Kander I, Scandrett K, et al. Evaluating whole genome sequencing for rare diseases in newborn screening: evidence synthesis from a series of systematic reviews. Health Technol Assess. 2025;29:1\u2013172. https:\/\/doi.org\/10.3310\/DJRF1124.","journal-title":"Health Technol Assess"},{"issue":"5","key":"4513_CR141","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/jimd.12508","volume":"45","author":"U M\u00fctze","year":"2022","unstructured":"M\u00fctze U, Mengler K, Boy N, Gleich F, Opladen T, Garbade SF, et al. How longitudinal observational studies can guide screening strategy for rare diseases. J Inherit Metab Dis. 2022;45(5):889\u2013901. https:\/\/doi.org\/10.1002\/jimd.12508.","journal-title":"J Inher Metab Disea"},{"issue":"1","key":"4513_CR142","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13073-023-01199-y","volume":"15","author":"AG Sharo","year":"2023","unstructured":"Sharo AG, Zou Y, Adhikari AN, Brenner SE. ClinVar and HGMD genomic variant classification accuracy has improved over time, as measured by implied disease burden. Genome Med. 2023;15(1):51. https:\/\/doi.org\/10.1186\/s13073-023-01199-y.","journal-title":"Genome Med"},{"key":"4513_CR143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/4955235","volume":"2023","author":"L Lin","year":"2023","unstructured":"Lin L, Pan H, Qi Y, Ma Y, Qiu L. Reasons and resolutions for inconsistent variant interpretation. Hum Mutat. 2023;2023:1\u201311. https:\/\/doi.org\/10.1155\/2023\/4955235.","journal-title":"Hum Mutat"},{"issue":"1","key":"4513_CR144","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/s41392-025-02267-y","volume":"10","author":"R Tan","year":"2025","unstructured":"Tan R, Hua H, Zhou S, Yang Z, Yang C, Huang G, et al. Current landscape of innovative drug development and regulatory support in China. Signal Transduct Target Ther. 2025;10(1):220. https:\/\/doi.org\/10.1038\/s41392-025-02267-y.","journal-title":"Sig Transduct Target Ther"},{"key":"4513_CR145","doi-asserted-by":"crossref","unstructured":"Li B, Tang Y, Huang Z, Ma L, Song J, Xue L. Synergistic innovation in organ-on-a-chip and organoid technologies: reshaping the future of disease modeling, drug development and precision medicine. Protein Cell. 2025.","DOI":"10.1093\/procel\/pwaf058"},{"key":"4513_CR146","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2147\/PHMT.S49329","volume":"7","author":"JC Rocha","year":"2016","unstructured":"Rocha JC, MacDonald A. Dietary intervention in the management of phenylketonuria: current perspectives. Patient Prefer Adherence. 2016;7:155\u201363. https:\/\/doi.org\/10.2147\/PHMT.S49329.","journal-title":"PHMT"},{"issue":"1","key":"4513_CR147","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1743-7075-9-7","volume":"9","author":"M Giovannini","year":"2012","unstructured":"Giovannini M, Verduci E, Salvatici E, Paci S, Riva E. Phenylketonuria: nutritional advances and challenges. Nutr Metab (Lond). 2012;9(1):7. https:\/\/doi.org\/10.1186\/1743-7075-9-7.","journal-title":"Nutr Metab (Lond)"},{"issue":"2","key":"4513_CR148","doi-asserted-by":"publisher","first-page":"100021","DOI":"10.1016\/j.bdcasr.2024.100021","volume":"2","author":"B Devanapalli","year":"2024","unstructured":"Devanapalli B, Wong RSH, Lim N, Andrews PI, Vijayan K, Kim W-T, et al. Biotinidase deficiency: a treatable neurometabolic disorder. Brain Dev Case Rep. 2024;2(2):100021. https:\/\/doi.org\/10.1016\/j.bdcasr.2024.100021.","journal-title":"Brain Devel Case Rep"},{"issue":"7","key":"4513_CR149","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1080\/14656566.2025.2491508","volume":"26","author":"A Corsini","year":"2025","unstructured":"Corsini A. Improving the treatment of pompe disease with enzyme replacement therapy: current strategies and clinical evidence. Expert Opin Pharmacother. 2025;26(7):835\u201348. https:\/\/doi.org\/10.1080\/14656566.2025.2491508.","journal-title":"Expert Opin Pharmacother"},{"issue":"3","key":"4513_CR150","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S1474-4422(24)00518-0","volume":"24","author":"NAME van der Beek","year":"2025","unstructured":"van der Beek NAME, Theunissen MTM, van den Hout JMP, Pijnappel WWM, Schoser B, Lafor\u00eat P, et al. Clinical insights in enzyme replacement therapy for metabolic storage disorders: lessons from Pompe disease. Lancet Neurol. 2025;24(3):230\u201345. https:\/\/doi.org\/10.1016\/S1474-4422(24)00518-0.","journal-title":"The Lancet Neurol"},{"issue":"1","key":"4513_CR151","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13023-023-02715-4","volume":"18","author":"IAM Ditters","year":"2023","unstructured":"Ditters IAM, van der Beek N, Brusse E, van der Ploeg AT, van den Hout JMP, Huidekoper HH. Home-based enzyme replacement therapy in children and adults with Pompe disease: a prospective study. Orphanet J Rare Dis. 2023;18(1):108. https:\/\/doi.org\/10.1186\/s13023-023-02715-4.","journal-title":"Orphanet J Rare Dis"},{"key":"4513_CR152","doi-asserted-by":"publisher","unstructured":"Porcari GS, Collyer JW, Adang LA, Rajan DS. Current advances and challenges in gene therapies for neurologic disorders: a review for the clinician. Neurol Genet. 2025;11(1):e200229. https:\/\/doi.org\/10.1212\/NXG.0000000000200229.","DOI":"10.1212\/NXG.0000000000200229"},{"issue":"9","key":"4513_CR153","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.molmed.2025.01.015","volume":"31","author":"O Devinsky","year":"2025","unstructured":"Devinsky O, Coller J, Ahrens-Nicklas R, Liu XS, Ahituv N, Davidson BL, et al. Gene therapies for neurogenetic disorders. Trends Mol Med. 2025;31(9):814\u201326. https:\/\/doi.org\/10.1016\/j.molmed.2025.01.015.","journal-title":"Trends Mol Med"},{"issue":"3","key":"4513_CR154","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/ijns10030049","volume":"10","author":"K Cooper","year":"2024","unstructured":"Cooper K, Nalbant G, Sutton A, Harnan S, Thokala P, Chilcott J, et al. Systematic review of newborn screening programmes for spinal muscular atrophy. Int J Neonatal Screen. 2024;10(3):10. https:\/\/doi.org\/10.3390\/ijns10030049.","journal-title":"IJNS"},{"issue":"3","key":"4513_CR155","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S2352-4642(22)00378-9","volume":"7","author":"H Nishio","year":"2023","unstructured":"Nishio H. Newborn screening for spinal muscular atrophy. Lancet Child Adolesc Health. 2023;7(3):146\u201347. https:\/\/doi.org\/10.1016\/S2352-4642(22)00378-9.","journal-title":"Lancet Child Adolesc Health"},{"issue":"6","key":"4513_CR156","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.nmd.2021.03.007","volume":"31","author":"T Dangouloff","year":"2021","unstructured":"Dangouloff T, Vr\u0161\u010daj E, Servais L, Osredkar D, Adoukonou T, Aryani O, et al. Newborn screening programs for spinal muscular atrophy worldwide: where we stand and where to go. Neuromuscul Disord. 2021;31(6):574\u201382. https:\/\/doi.org\/10.1016\/j.nmd.2021.03.007.","journal-title":"Neuromuscul Disord"},{"key":"4513_CR157","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ejpn.2024.03.003","volume":"49","author":"L Laugwitz","year":"2024","unstructured":"Laugwitz L, Schoenmakers DH, Adang LA, Beck-Woedl S, Bergner C, Bernard G, et al. Newborn screening in metachromatic leukodystrophy \u2013 European consensus-based recommendations on clinical management. Eur J Paediatr Neurol. 2024;49:141\u201354. https:\/\/doi.org\/10.1016\/j.ejpn.2024.03.003.","journal-title":"Eur J Paediatric Neurol"},{"issue":"4","key":"4513_CR158","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/ijns11040103","volume":"11","author":"L Laugwitz","year":"2025","unstructured":"Laugwitz L, Shenker A, Sluys EF, Pintat S, Whiteman D, Chanson C. Newborn screening for metachromatic leukodystrophy: a systematic literature review. Int J Neonatal Screen. 2025;11(4):11. https:\/\/doi.org\/10.3390\/ijns11040103.","journal-title":"IJNS"},{"key":"4513_CR159","doi-asserted-by":"publisher","unstructured":"Lam WKK, Ream MA, Grosse SD, Ojodu J, Jones E, Smith HS, et al. Evidence regarding metachromatic leukodystrophy newborn screening. Pediatrics. 2025. https:\/\/doi.org\/10.1542\/peds.2025-073188.","DOI":"10.1542\/peds.2025-073188"},{"issue":"3","key":"4513_CR160","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41436-020-01017-5","volume":"23","author":"X Hong","year":"2021","unstructured":"Hong X, Daiker J, Sadilek M, Ruiz-Schultz N, Kumar AB, Norcross S, et al. Toward newborn screening of metachromatic leukodystrophy: results from analysis of over 27, 000 newborn dried blood spots. Genet Med. 2021;23(3):555\u201361. https:\/\/doi.org\/10.1038\/s41436-020-01017-5.","journal-title":"Genet Med"},{"issue":"13","key":"4513_CR161","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1056\/NEJMc2407165","volume":"391","author":"L Laugwitz","year":"2024","unstructured":"Laugwitz L, Mechtler TP, Janzen N, Oliva P, Kasper AR, Teunissen CE, et al. Newborn screening and presymptomatic treatment of metachromatic leukodystrophy. N Engl J Med. 2024;391(13):1256\u201358. https:\/\/doi.org\/10.1056\/NEJMc2407165.","journal-title":"N Engl J Med"},{"issue":"4","key":"4513_CR162","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/ijns9040064","volume":"9","author":"J Prinzi","year":"2023","unstructured":"Prinzi J, Pasquali M, Hobert JA, Palmquist R, Wong KN, Francis S, et al. Diagnosing X-Linked adrenoleukodystrophy after implementation of newborn screening: a reference laboratory perspective. Int J Neonatal Screen. 2023;9(4):9. https:\/\/doi.org\/10.3390\/ijns9040064.","journal-title":"IJNS"},{"issue":"4","key":"4513_CR163","doi-asserted-by":"publisher","first-page":"107734","DOI":"10.1016\/j.ymgme.2023.107734","volume":"140","author":"C Videb\u00e6k","year":"2023","unstructured":"Videb\u00e6k C, Melgaard L, Lund AM, Gr\u00f8nborg SW. Newborn screening for adrenoleukodystrophy: international experiences and challenges. Mol Genet Metab. 2023;140(4):107734. https:\/\/doi.org\/10.1016\/j.ymgme.2023.107734.","journal-title":"Mol Genet Metab"},{"issue":"11","key":"4513_CR164","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1038\/s41591-025-03945-8","volume":"31","author":"HL Cope","year":"2025","unstructured":"Cope HL, Jalazo ER, Berg JS, Sullivan JA, Kucera KS, Shone SM, et al. Feasibility and clinical utility of expanded genomic newborn screening in the Early Check program. Nat Med. 2025;31(11):3762\u201371. https:\/\/doi.org\/10.1038\/s41591-025-03945-8.","journal-title":"Nat Med"},{"key":"4513_CR165","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cca.2019.12.022","volume":"502","author":"C Yang","year":"2020","unstructured":"Yang C, Zhou C, Xu P, Jin X, Liu W, Wang W, et al. Newborn screening and diagnosis of inborn errors of metabolism: a 5-year study in an eastern Chinese population. Clin Chim Acta. 2020;502:133\u201338. https:\/\/doi.org\/10.1016\/j.cca.2019.12.022.","journal-title":"Clinica (Rome) Acta"},{"issue":"4","key":"4513_CR166","doi-asserted-by":"publisher","first-page":"274","DOI":"10.2174\/1573396318666220404194452","volume":"18","author":"S Mukherjee","year":"2022","unstructured":"Mukherjee S, Ray SK. Inborn errors of metabolism screening in neonates: current perspective with diagnosis and therapy. Curr Pharm Rep. 2022;18(4):274\u201385. https:\/\/doi.org\/10.2174\/1573396318666220404194452.","journal-title":"CPR"},{"issue":"9750","key":"4513_CR167","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(10)60961-0","volume":"376","author":"N Blau","year":"2010","unstructured":"Blau N, van Spronsen FJ, Levy HL. Phenylketonuria. Lancet. 2010;376(9750):1417\u201327. https:\/\/doi.org\/10.1016\/S0140-6736(10)60961-0.","journal-title":"Lancet"},{"issue":"1","key":"4513_CR168","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s43587-020-00006-2","volume":"1","author":"NE Richardson","year":"2021","unstructured":"Richardson NE, Konon EN, Schuster HS, Mitchell AT, Boyle C, Rodgers AC, et al. Lifelong restriction of dietary branched-chain amino acids has sex-specific benefits for frailty and lifespan in mice. Nat Aging. 2021;1(1):73\u201386. https:\/\/doi.org\/10.1038\/s43587-020-00006-2.","journal-title":"Nat Aging"},{"key":"4513_CR169","doi-asserted-by":"publisher","unstructured":"Furnham N, Sillitoe I, Holliday GL, Cuff AL, Laskowski RA, Orengo CA, et al. Exploring the evolution of novel enzyme functions within structurally defined protein superfamilies. PLoS Comput Biol. 2012;8(3):e1002403. https:\/\/doi.org\/10.1371\/journal.pcbi.1002403.","DOI":"10.1371\/journal.pcbi.1002403"},{"issue":"9","key":"4513_CR170","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1002\/anie.200803098","volume":"48","author":"L Fruk","year":"2009","unstructured":"Fruk L, Kuo CH, Torres E, Niemeyer CM. Apoenzyme reconstitution as a chemical tool for structural enzymology and biotechnology. Angew Chem Int Ed Engl. 2009;48(9):1550\u201374. https:\/\/doi.org\/10.1002\/anie.200803098.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1\u20132","key":"4513_CR171","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ymgme.2011.05.014","volume":"104","author":"S Stockler","year":"2011","unstructured":"Stockler S, Plecko B, Gospe SM, Coulter-Mackie M, Connolly M, van Karnebeek C, et al. Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up. Mol Genet Metab. 2011;104(1\u20132):48\u201360. https:\/\/doi.org\/10.1016\/j.ymgme.2011.05.014.","journal-title":"Mol Genet Metab"},{"issue":"5","key":"4513_CR172","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1083\/jcb.201208152","volume":"199","author":"FM Platt","year":"2012","unstructured":"Platt FM, Boland B, van der Spoel AC. The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction. J Cell Biol. 2012;199(5):723\u201334. https:\/\/doi.org\/10.1083\/jcb.201208152.","journal-title":"J Cell Biol"},{"issue":"01","key":"4513_CR173","doi-asserted-by":"publisher","first-page":"051","DOI":"10.1055\/s-0036-1593843","volume":"6","author":"RW Peake","year":"2016","unstructured":"Peake RW, Bodamer OA. Newborn screening for lysosomal storage disorders. J Pediatr Genet. 2016;6(01):051\u2013060. https:\/\/doi.org\/10.1055\/s-0036-1593843.","journal-title":"J Pediatr Genet"},{"issue":"1","key":"4513_CR174","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ajmg.c.32033","volume":"193","author":"PJ Brooks","year":"2023","unstructured":"Brooks PJ, Urv TK, Parisi MA. Gene-targeted therapies: overview and implications. Am J Med Genet C Semin Med Genet. 2023;193(1):13\u201318. https:\/\/doi.org\/10.1002\/ajmg.c.32033.","journal-title":"Am J Med Genet Pt C"},{"issue":"1","key":"4513_CR175","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41392-024-02039-0","volume":"9","author":"W Dai","year":"2024","unstructured":"Dai W, Qiao X, Fang Y, Guo R, Bai P, Liu S, et al. Epigenetics-targeted drugs: current paradigms and future challenges. Signal Transduct Target Ther. 2024;9(1):332. https:\/\/doi.org\/10.1038\/s41392-024-02039-0.","journal-title":"Sig Transduct Target Ther"},{"issue":"6","key":"4513_CR176","doi-asserted-by":"publisher","first-page":"436","DOI":"10.2174\/0113892037336137250102104842","volume":"26","author":"K Gupta","year":"2025","unstructured":"Gupta K, Sharma V, Siddiqui T. Transforming medicine: advances in gene therapy, immunotherapy, and targeted cures. Curr Pharm Des. 2025;26(6):436\u201350. https:\/\/doi.org\/10.2174\/0113892037336137250102104842.","journal-title":"CPPS"},{"key":"4513_CR177","doi-asserted-by":"publisher","unstructured":"Cetin B, Erendor F, Eksi YE, Sanlioglu AD, Sanlioglu S. Gene and cell therapy of human genetic diseases: recent advances and future directions. J Cell Mol Med. 2024;28(17):e70056. https:\/\/doi.org\/10.1111\/jcmm.70056.","DOI":"10.1111\/jcmm.70056"},{"issue":"4","key":"4513_CR178","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/s41591-024-03465-x","volume":"31","author":"F Boemer","year":"2025","unstructured":"Boemer F, Hovhannesyan K, Piazzon F, Minner F, Mni M, Jacquemin V, et al. Population-based, first-tier genomic newborn screening in the maternity ward. Nat Med. 2025;31(4):1339\u201350. https:\/\/doi.org\/10.1038\/s41591-024-03465-x.","journal-title":"Nat Med"},{"issue":"4","key":"4513_CR179","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/healthcare12040445","volume":"12","author":"CD Laureano","year":"2024","unstructured":"Laureano CD, Laranjeira C, Querido A, Dixe MA, Rego F. Ethical issues in clinical decision-making about involuntary psychiatric treatment: a scoping review. Healthcare (Basel). 2024;12(4):12. https:\/\/doi.org\/10.3390\/healthcare12040445.","journal-title":"Healthcare (Basel)"},{"issue":"10","key":"4513_CR180","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s41431-022-01055-4","volume":"30","author":"S Kalkman","year":"2022","unstructured":"Kalkman S, Dondorp W. The case for screening in early life for \u2018non-treatable\u2019 disorders: ethics, evidence and proportionality. A report from the Health council of the Netherlands. Eur J Hum Genet. 2022;30(10):1155\u201358. https:\/\/doi.org\/10.1038\/s41431-022-01055-4.","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"4513_CR181","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1542\/peds.2023-061727","volume":"152","author":"SA Sobotka","year":"2023","unstructured":"Sobotka SA, Ross LF. Newborn screening for neurodevelopmental disorders may exacerbate health disparities. Pediatrics. 2023;152(4):152. https:\/\/doi.org\/10.1542\/peds.2023-061727.","journal-title":"Pediatrics"},{"key":"4513_CR182","doi-asserted-by":"publisher","unstructured":"McElwee F, Sansom SL, Buchanan J, Taylor JC, Wordsworth S. The cost and cost-effectiveness of whole-exome and whole-genome sequencing: a systematic literature review. Eur J Hum Genet. 2026. https:\/\/doi.org\/10.1038\/s41431-026-02146-2.","DOI":"10.1038\/s41431-026-02146-2"},{"issue":"4","key":"4513_CR183","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.healthpol.2022.03.001","volume":"126","author":"MC Nurchis","year":"2022","unstructured":"Nurchis MC, Riccardi MT, Radio FC, Chillemi G, Bertini ES, Tartaglia M, et al. Incremental net benefit of whole genome sequencing for newborns and children with suspected genetic disorders: systematic review and meta-analysis of cost-effectiveness evidence. Health Policy. 2022;126(4):337\u201345. https:\/\/doi.org\/10.1016\/j.healthpol.2022.03.001.","journal-title":"Health Policy (New Y)"},{"key":"4513_CR184","doi-asserted-by":"publisher","first-page":"114889","DOI":"10.1016\/j.jpeds.2025.114889","volume":"289","author":"TA Lavelle","year":"2026","unstructured":"Lavelle TA, Maron JL, Kingsmore SF, Lin CH, Zhu Y, Sweigart B, et al. Rapid genome sequencing compared with a gene panel in critically Ill infants with a suspected genetic disorder: an economic evaluation. J Pediat. 2026;289:114889. https:\/\/doi.org\/10.1016\/j.jpeds.2025.114889.","journal-title":"J Pediatrics"},{"key":"4513_CR185","doi-asserted-by":"publisher","unstructured":"Maron JL, Kingsmore SF, Wigby K, Chowdhury S, Dimmock D, Poindexter B, et al. Novel variant findings and challenges associated with the clinical integration of genomic testing: an interim report of the Genomic Medicine for Ill Neonates and Infants (GEMINI) study. JAMA Pediat. 2021;175(5):e205906. https:\/\/doi.org\/10.1001\/jamapediatrics.2020.5906.","DOI":"10.1001\/jamapediatrics.2020.5906"},{"issue":"2","key":"4513_CR186","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40258-025-01013-3","volume":"24","author":"R Lamsal","year":"2026","unstructured":"Lamsal R, Smith HS, Grosse SD. Data-related and methodological challenges in assessing the cost-effectiveness of traditional and genomic newborn screening programs. Appl Health Econ Health Policy. 2026;24(2):271\u201386. https:\/\/doi.org\/10.1007\/s40258-025-01013-3.","journal-title":"Appl Health Econ Health Policy"},{"issue":"1","key":"4513_CR187","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12913-025-12419-z","volume":"25","author":"S Zhou","year":"2025","unstructured":"Zhou S, Xiao D, Huang Z, Weng J, Luo B, Chen Y. Cost-effectiveness analysis of tandem mass spectrometry compared to fluorescence analysis for screening neonatal genetic metabolic diseases. BMC Health Serv Res. 2025;25(1):272. https:\/\/doi.org\/10.1186\/s12913-025-12419-z.","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"4513_CR188","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/ijns10030042","volume":"10","author":"AJ Ashenden","year":"2024","unstructured":"Ashenden AJ, Chowdhury A, Anastasi LT, Lam K, Rozek T, Ranieri E, et al. The multi-omic approach to newborn screening: opportunities and challenges. Int J Neonatal Screen. 2024;10(3):10. https:\/\/doi.org\/10.3390\/ijns10030042.","journal-title":"IJNS"},{"key":"4513_CR189","doi-asserted-by":"publisher","unstructured":"Reimers R, Bailey M, Brown C, Chan K, Defay T, Finkel T, et al. Clinical utility and cost-effectiveness of BeginNGS newborn screening by genome sequencing and standard newborn screening for severe childhood genetic diseases: an adaptive, international and comparative clinical trial. BMJ Open. 2025;15(11):e098609. https:\/\/doi.org\/10.1136\/bmjopen-2024-098609.","DOI":"10.1136\/bmjopen-2024-098609"},{"key":"4513_CR190","doi-asserted-by":"publisher","unstructured":"Anastasi L, Chowdhury A, Ashenden A, Rozek T, Louise J, Lam K, et al. NewbornsInSA multi-omic newborn screening: protocol for a prospective cohort study. BMJ Open. 2026;16(3):e108406. https:\/\/doi.org\/10.1136\/bmjopen-2025-108406.","DOI":"10.1136\/bmjopen-2025-108406"},{"key":"4513_CR191","doi-asserted-by":"publisher","unstructured":"Level C, Thauvin-Robinet C, Binquet C, Duffourd Y, Davoine E, Chevarin M, et al. PERIGENOMED-CLINICS 1\u2014the first study on feasibility, acceptability and psychosocial impact of PERIGENOMED: a pilot project aimed at providing initial concrete evidence on the relevance of panel-based genome sequencing for newborn screening (NBS) in France. BMJ Open. 2025;15(10):e105752. https:\/\/doi.org\/10.1136\/bmjopen-2025-105752.","DOI":"10.1136\/bmjopen-2025-105752"},{"issue":"8","key":"4513_CR192","doi-asserted-by":"publisher","first-page":"926","DOI":"10.3390\/children11080926","volume":"11","author":"T Dangouloff","year":"2024","unstructured":"Dangouloff T, Hovhannesyan K, Mashhadizadeh D, Minner F, Mni M, Helou L, et al. Feasibility and acceptability of a newborn screening program using targeted next-generation sequencing in one maternity hospital in Southern Belgium. Children (Basel). 2024;11(8):926. https:\/\/doi.org\/10.3390\/children11080926.","journal-title":"Children"},{"issue":"2","key":"4513_CR193","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/ijns10020033","volume":"10","author":"WK Chung","year":"2024","unstructured":"Chung WK, Kanne SM, Hu Z. An opportunity to fill a gap for newborn screening of neurodevelopmental disorders. Int J Neonatal Screen. 2024;10(2):10. https:\/\/doi.org\/10.3390\/ijns10020033.","journal-title":"IJNS"},{"issue":"12","key":"4513_CR194","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.1038\/s41591-025-03986-z","volume":"31","author":"S Lunke","year":"2025","unstructured":"Lunke S, Downie L, Caruana J, Kugenthiran N, Fazio PD, Hollizeck S, et al. Feasibility, acceptability and clinical outcomes of the BabyScreen+ genomic newborn screening study. Nat Med. 2025;31(12):4236\u201345. https:\/\/doi.org\/10.1038\/s41591-025-03986-z.","journal-title":"Nat Med"},{"issue":"5","key":"4513_CR195","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s12687-024-00721-y","volume":"15","author":"S Walters","year":"2024","unstructured":"Walters S, Aldous C, Malherbe H. Knowledge, attitudes, and practices of primary healthcare practitioners in low- and middle-income countries: a scoping review on genetics. J Community Genet. 2024;15(5):461\u201374. https:\/\/doi.org\/10.1007\/s12687-024-00721-y.","journal-title":"J Community Genet"},{"issue":"3","key":"4513_CR196","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/gm324","volume":"4","author":"SF Kingsmore","year":"2012","unstructured":"Kingsmore SF, Lantos JD, Dinwiddie DL, Miller NA, Soden SE, Farrow EG, et al. Next-generation community genetics for low- and middle-income countries. Genome Med. 2012;4(3):25. https:\/\/doi.org\/10.1186\/gm324.","journal-title":"Genome Med"},{"issue":"11","key":"4513_CR197","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1038\/s41431-024-01633-8","volume":"32","author":"S Best","year":"2024","unstructured":"Best S, Fehlberg Z, Richards C, Quinn MCJ, Lunke S, Spurdle AB, et al. Reanalysis of genomic data in rare disease: current practice and attitudes among Australian clinical and laboratory genetics services. Eur J Hum Genet. 2024;32(11):1428\u201335. https:\/\/doi.org\/10.1038\/s41431-024-01633-8.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"4513_CR198","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41525-020-00140-1","volume":"5","author":"KN James","year":"2020","unstructured":"James KN, Clark MM, Camp B, Kint C, Schols P, Batalov S, et al. Partially automated whole-genome sequencing reanalysis of previously undiagnosed pediatric patients can efficiently yield new diagnoses. NPJ Genom Med. 2020;5(1):33. https:\/\/doi.org\/10.1038\/s41525-020-00140-1.","journal-title":"npj Genom. Med"},{"issue":"5","key":"4513_CR199","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41431-025-01823-y","volume":"33","author":"C Thauvin-Robinet","year":"2025","unstructured":"Thauvin-Robinet C, Garde A, Favier M, Delanne J, Racine C, Rousseau T, et al. Reanalysis of unsolved prenatal exome sequencing for structural defects: diagnostic yield and contribution of postnatal\/postmortem features. Eur J Hum Genet. 2025;33(5):675\u201382. https:\/\/doi.org\/10.1038\/s41431-025-01823-y.","journal-title":"Eur J Hum Genet"},{"key":"4513_CR200","doi-asserted-by":"publisher","unstructured":"Nguyen JNH, Lachgar-Ruiz M, Higginbotham EJ, Coleman M, Coleman J, Shao W, et al. Diagnostic yield of comprehensive reanalysis after nondiagnostic short-read genome sequencing in infants with unexplained epilepsy. Neurology. 2026;106(6):e214645. https:\/\/doi.org\/10.1212\/WNL.0000000000214645.","DOI":"10.1212\/WNL.0000000000214645"},{"key":"4513_CR201","doi-asserted-by":"publisher","unstructured":"Carli D, Quarello P, Porta F, Cagnazzo C, Zucchetti G, Proto CF, et al. A genomic sequencing approach to newborn mass screening and its opportunities. JAMA Netw Open. 2025;8(10):e2538198. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.38198.","DOI":"10.1001\/jamanetworkopen.2025.38198"},{"key":"4513_CR202","doi-asserted-by":"publisher","first-page":"101841","DOI":"10.1016\/j.gimo.2024.101841","volume":"2","author":"L Li","year":"2024","unstructured":"Li L, Tian X, Woodzell V, Gibbs RA, Yuan B, Venner E. Tracking updates in clinical databases increases efficiency for variant reanalysis. Genet Med Open. 2024;2:101841. https:\/\/doi.org\/10.1016\/j.gimo.2024.101841.","journal-title":"Genet Med Open"},{"key":"4513_CR203","doi-asserted-by":"publisher","unstructured":"Hills S, Li Q, Madden JA, Genetti CA, Brownstein CA, Schmitz-Abe K, et al. High number of candidate gene variants are identified as disease-causing in a period of 4 years. Am J Med Genet A. 2024;194(5):e63509. https:\/\/doi.org\/10.1002\/ajmg.a.63509.","DOI":"10.1002\/ajmg.a.63509"},{"issue":"1","key":"4513_CR204","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/ijns7010002","volume":"7","author":"HL Levy","year":"2021","unstructured":"Levy HL. Ethical and psychosocial implications of genomic newborn screening. Int J Neonatal Screen. 2021;7(1):2 https:\/\/doi.org\/10.3390\/ijns7010002.","journal-title":"IJNS"},{"issue":"1","key":"4513_CR205","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12910-025-01331-0","volume":"26","author":"G Watts","year":"2025","unstructured":"Watts G, Otlowski M, Banks R, Newson AJ. Three ethical approaches to expanding newborn screening through genomics: a critical comparative analysis. BMC Med Ethics. 2025;26(1):167. https:\/\/doi.org\/10.1186\/s12910-025-01331-0.","journal-title":"BMC Med Ethics"},{"key":"4513_CR206","doi-asserted-by":"publisher","unstructured":"Tariq H, Salpietro V, Houlden H, Stevanin G. Globalizing newborn screening: bridging gaps in genetic diagnosis and treatment. Front Pediatr. 2025;13:- 2025. https:\/\/doi.org\/10.3389\/fped.2025.1672993.","DOI":"10.3389\/fped.2025.1672993"},{"issue":"1","key":"4513_CR207","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41525-024-00451-7","volume":"9","author":"JM Friedman","year":"2024","unstructured":"Friedman JM. Implementing genomic newborn screening as an effective public health intervention: sidestepping the hype and criticism. NPJ Genom. Med. 2024;9(1):70. https:\/\/doi.org\/10.1038\/s41525-024-00451-7.","journal-title":"npj Genom. Med"},{"issue":"1","key":"4513_CR208","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/clinchem\/hvae180","volume":"71","author":"M Jeanne","year":"2025","unstructured":"Jeanne M, Chung WK. DNA sequencing in newborn screening: opportunities, challenges, and future directions. Clin Chem. 2025;71(1):77\u201386. https:\/\/doi.org\/10.1093\/clinchem\/hvae180.","journal-title":"Clin Chem"},{"issue":"2","key":"4513_CR209","doi-asserted-by":"publisher","first-page":"104394","DOI":"10.1016\/j.respol.2021.104394","volume":"51","author":"R Kaplinsky","year":"2022","unstructured":"Kaplinsky R, Kraemer-Mbula E. Innovation and uneven development: the challenge for low- and middle-income economies. Res Policy. 2022;51(2):104394. https:\/\/doi.org\/10.1016\/j.respol.2021.104394.","journal-title":"Res Policy"},{"key":"4513_CR210","doi-asserted-by":"publisher","first-page":"0059","DOI":"10.34133\/bdr.0059","volume":"6","author":"Y Luo","year":"2024","unstructured":"Luo Y, Zhao C, Chen F. Multiomics research: principles and challenges in integrated analysis. Biodes Res. 2024;6:0059. https:\/\/doi.org\/10.34133\/bdr.0059.","journal-title":"Biodes Res"},{"issue":"1","key":"4513_CR211","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13040-025-00442-z","volume":"18","author":"W Jiang","year":"2025","unstructured":"Jiang W, Ye W, Tan X, Bao Y-J. Network-based multi-omics integrative analysis methods in drug discovery: a systematic review. BMC Bioinformatics. 2025;18(1):27. https:\/\/doi.org\/10.1186\/s13040-025-00442-z.","journal-title":"Biodata Min"},{"issue":"1","key":"4513_CR212","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41540-025-00591-1","volume":"11","author":"M Moscard\u00f3 Garc\u00eda","year":"2025","unstructured":"Moscard\u00f3 Garc\u00eda M, Aalto A, Montanari AN, Skupin A, Gon\u00e7alves J. Multi-omic network inference from time-series data. npj systems biology and applications. 2025. NPJ Syst Biol Appl. 2025;11(1):114. https:\/\/doi.org\/10.1038\/s41540-025-00591-1.","journal-title":"NPJ Syst Biol Appl"},{"issue":"1","key":"4513_CR213","doi-asserted-by":"publisher","first-page":"108098","DOI":"10.1016\/j.ymgme.2023.108098","volume":"141","author":"L Hao","year":"2024","unstructured":"Hao L, Liang L, Gao X, Zhan X, Ji W, Chen T, et al. Screening of 1.17 million newborns for inborn errors of metabolism using tandem mass spectrometry in Shanghai, China: a 19-year report. Mol Genet Metab. 2024;141(1):108098. https:\/\/doi.org\/10.1016\/j.ymgme.2023.108098.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"4513_CR214","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41598-025-33087-3","volume":"16","author":"D Han","year":"2025","unstructured":"Han D, Tao Y, Li J, Wang L, Song W, Li X. Newborn screening for inherited metabolic disorders in central China: a retrospective study of 153, 956 infants using non-derivatized tandem mass spectrometry. Sci Rep. 2025;16(1):645. https:\/\/doi.org\/10.1038\/s41598-025-33087-3.","journal-title":"Sci Rep"},{"key":"4513_CR215","doi-asserted-by":"publisher","first-page":"1617418","DOI":"10.3389\/fgene.2025.1617418","volume":"16","author":"H Zhang","year":"2025","unstructured":"Zhang H, Tian H, Dai W, Zhang L, Guo G, Ding G. Expanded newborn screening for inborn errors of metabolism and genetic variants in Xinjiang, China. Front Genet. 2025;16:1617418. https:\/\/doi.org\/10.3389\/fgene.2025.1617418.","journal-title":"Front Genet"},{"issue":"1","key":"4513_CR216","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/s13023-025-03848-4","volume":"20","author":"T Onuki","year":"2025","unstructured":"Onuki T, Tajika M, Sugiyama Y, Shimura M, Ichimoto K, Tanaka T, et al. Japanese experience of newborn screening for lysosomal storage diseases and adrenoleukodystrophy. Orphanet J Rare Dis. 2025;20(1):373. https:\/\/doi.org\/10.1186\/s13023-025-03848-4.","journal-title":"Orphanet J Rare Dis"},{"key":"4513_CR217","doi-asserted-by":"crossref","unstructured":"Wichajarn K, Sawatjui N, Prasongdee P, Panklin A, Sornkayasit K, Chungkanchana N, et al. The establishment of expanded newborn screening in rural areas of a developing country: a model from health regions 7 and 8 in Thailand. Int J Neonatal Screen. 2025;11.","DOI":"10.20944\/preprints202501.1881.v1"},{"key":"4513_CR218","doi-asserted-by":"publisher","unstructured":"Bisht A, Hasija Y. Revolutionizing neonatal health: India\u2019s journey from assays to advanced genetics. J Appl Genet. 2025. https:\/\/doi.org\/10.1007\/s13353-025-01012-z.","DOI":"10.1007\/s13353-025-01012-z"},{"issue":"1","key":"4513_CR219","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3343\/alm.2025.0645","volume":"46","author":"IS Kim","year":"2026","unstructured":"Kim IS. Reinterpreting national whole-genome sequencing data: lessons from the first Korean pilot study. Ann Lab Med. 2026;46(1):1\u20132. https:\/\/doi.org\/10.3343\/alm.2025.0645.","journal-title":"Ann Lab Med"},{"issue":"1","key":"4513_CR220","doi-asserted-by":"publisher","first-page":"6096758","DOI":"10.1155\/humu\/6096758","volume":"2025","author":"R Khang","year":"2025","unstructured":"Khang R, Lee H, Kim J, Moon D, Jang S, Lee E, et al. Genome sequencing of rare disease patients through the Korean regional rare disease diagnostic support program. Hum Mutat. 2025;2025(1):6096758. https:\/\/doi.org\/10.1155\/humu\/6096758.","journal-title":"Hum Mutat"},{"issue":"1","key":"4513_CR221","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.4102\/ajlm.v14i1.2973","volume":"14","author":"T Satekge","year":"2025","unstructured":"Satekge T, Okesina A, Anetor J, Erasmus R. The status of newborn screening in Africa: situation analysis, future plans and call to action. Afr J Lab Med. 2025;14(1):2973. https:\/\/doi.org\/10.4102\/ajlm.v14i1.2973.","journal-title":"Afr J Lab Med"},{"issue":"1","key":"4513_CR222","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/ijns12010005","volume":"12","author":"OS Folayan","year":"2026","unstructured":"Folayan OS, Orimadegun BE, Ayede AI, Inusa BP, Kase MK, Anetor JI. Integrated newborn screening in Nigeria: the way forward, a workshop report. Int J Neonatal Screen. 2026;12(1):12. https:\/\/doi.org\/10.3390\/ijns12010005.","journal-title":"IJNS"},{"issue":"4","key":"4513_CR223","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s12687-024-00762-3","volume":"16","author":"CFM de Souza","year":"2025","unstructured":"de Souza CFM, Tonon T, Silva TO, Bachega T. Newborn screening in Brazil: realities and challenges. J Community Genet. 2025;16(4):431\u201338. https:\/\/doi.org\/10.1007\/s12687-024-00762-3.","journal-title":"J Community Genet"},{"issue":"3","key":"4513_CR224","doi-asserted-by":"publisher","first-page":"16","DOI":"10.20517\/rdodj.2024.02","volume":"3","author":"C Gonzaga-Jauregui","year":"2024","unstructured":"Gonzaga-Jauregui C, Moreno-Salgado R, Tovar-Casas J, Navarrete-Mart\u00ednez JI. Newborn screening in Mexico and Latin America: present and future. Rare Dis Orphan Drugs J. 2024;3(3):16. https:\/\/doi.org\/10.20517\/rdodj.2024.02.","journal-title":"Rare Dis Orphan Drugs J"},{"issue":"3","key":"4513_CR225","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/ijns11030051","volume":"11","author":"LC Reis","year":"2025","unstructured":"Reis LC, Tonon T, Acosta MB, Castro SMD, Coutinho VDLS, Melo DG, et al. Training primary healthcare professionals for expanded newborn screening with tandem mass spectrometry: challenges for community genetics in Brazil. Int J Neonatal Screen. 2025;11(3):11. https:\/\/doi.org\/10.3390\/ijns11030051.","journal-title":"IJNS"},{"issue":"6","key":"4513_CR226","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s12687-025-00826-y","volume":"16","author":"PLP Rojas","year":"2025","unstructured":"Rojas PLP, Mora LM, Rinc\u00f3n JS, Montoya IZ, Le\u00f3n-Sanabria MC, Urue\u00f1a-Serrano AM. Strengthening medical genetics and genomic medicine in Colombia: progress, challenges, and strategic opportunities. J Community Genet. 2025;16(6):705\u201319. https:\/\/doi.org\/10.1007\/s12687-025-00826-y.","journal-title":"J Community Genet"},{"issue":"3","key":"4513_CR227","doi-asserted-by":"publisher","first-page":"113","DOI":"10.25100\/cm.v48i3.2180","volume":"48","author":"N C\u00e9spedes","year":"2017","unstructured":"C\u00e9spedes N, Valencia A, Echeverry CA, Arce-Plata MI, Col\u00f3n C, Casti\u00f1eiras DE, et al. Reference values of amino acids, acylcarnitines and succinylacetone by tandem mass spectrometry for use in newborn screening in southwest Colombia. Colomb Med (Cali). 2017;48(3):113\u201319. https:\/\/doi.org\/10.25100\/cm.v48i3.2180.","journal-title":"Colomb Med (Cali)"},{"issue":"1","key":"4513_CR228","doi-asserted-by":"publisher","first-page":"143","DOI":"10.11124\/JBIES-23-00540","volume":"23","author":"K Kachroo","year":"2025","unstructured":"Kachroo K, Johnson AN, Moinudeen SAK, Sharma J, Holly C. Epidemiological burden of inborn errors of metabolism in low- and middle-income countries: a systematic review protocol. JBI Evid Synth. 2025;23(1):143\u201349. https:\/\/doi.org\/10.11124\/JBIES-23-00540.","journal-title":"JBI Evidence Synth"},{"issue":"1","key":"4513_CR229","doi-asserted-by":"publisher","first-page":"7","DOI":"10.20517\/rdodj.2023.49","volume":"3","author":"HL Malherbe","year":"2024","unstructured":"Malherbe HL, Bonham J, Carrihill M, Chetty K, Conradie EH, Dercksen M, et al. Newborn screening in South Africa: the past, present, and plans for the future. Rare Dis Orphan Drugs J. 2024;3(1):7. https:\/\/doi.org\/10.20517\/rdodj.2023.49.","journal-title":"Rare Dis Orphan Drugs J"},{"issue":"3","key":"4513_CR230","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/s44197-024-00263-z","volume":"14","author":"N Alhusseini","year":"2024","unstructured":"Alhusseini N, Almuhanna Y, Alabduljabbar L, Alamri S, Altayeb M, Askar G, et al. International newborn screening: where are we in Saudi Arabia? J Epidemiol Glob Health. 2024;14(3):638\u201344. https:\/\/doi.org\/10.1007\/s44197-024-00263-z.","journal-title":"J Epidemiol Glob Health"},{"issue":"3","key":"4513_CR231","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/ijns10030047","volume":"10","author":"N Heather","year":"2024","unstructured":"Heather N, Greaves RF, Bhattacharya K, Greed L, Pitt J, Siu CW-K, et al. Counting conditions on newborn bloodspot screening panels in Australia and New Zealand. Int J Neonatal Screen. 2024;10(3):10. https:\/\/doi.org\/10.3390\/ijns10030047.","journal-title":"IJNS"},{"issue":"2","key":"4513_CR232","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1017\/cjn.2023.34","volume":"51","author":"E Groulx-Boivin","year":"2024","unstructured":"Groulx-Boivin E, Osman H, Chakraborty P, Lintern S, Oskoui M, Selby K, et al. Variability in newborn screening across Canada: spinal muscular atrophy and beyond. Can J Neurol Sci. 2024;51(2):203\u201309. https:\/\/doi.org\/10.1017\/cjn.2023.34.","journal-title":"Can J Neurol Sci"},{"key":"4513_CR233","doi-asserted-by":"publisher","unstructured":"Iroh Tam P-Y, Padilla CD, Zlotkin S, Ayede AI, Banu T, Kayita J, et al. The 77th World Health Assembly resolution calling for newborn screening, diagnosis, and management of birth defects: moving towards action in low-income and middle-income countries. Lancet Glob Health. 2024;12(11):e1754\u201355. https:\/\/doi.org\/10.1016\/S2214-109X(24)00335-8.","DOI":"10.1016\/S2214-109X(24)00335-8"},{"key":"4513_CR234","doi-asserted-by":"publisher","unstructured":"Brown GL, Walker L, Afolabi MA, Bain PA, Bonilha A, Chaudhari BP, et al. Genomic newborn screening: a scoping review of the field\u2019s evolution and associated ethical, legal, and social implications. Eur J Hum Genet. 2026. https:\/\/doi.org\/10.1038\/s41431-026-02108-8.","DOI":"10.1038\/s41431-026-02108-8"},{"issue":"6117","key":"4513_CR235","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1126\/science.1229566","volume":"339","author":"M Gymrek","year":"2013","unstructured":"Gymrek M, McGuire AL, Golan D, Halperin E, Erlich Y. Identifying personal genomes by surname inference. Science. 2013;339(6117):321\u201324. https:\/\/doi.org\/10.1126\/science.1229566.","journal-title":"Science"},{"issue":"1","key":"4513_CR236","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1891\/0739-6686.29.113","volume":"29","author":"R Anderson","year":"2011","unstructured":"Anderson R, Rothwell E, Botkin JR. Newborn screening: ethical, legal, and social implications. Annu Rev Nurs Res. 2011;29(1):113\u201332. https:\/\/doi.org\/10.1891\/0739-6686.29.113.","journal-title":"Annu Rev Nurs Res"},{"issue":"4","key":"4513_CR237","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41576-026-00936-4","volume":"27","author":"ACF Lewis","year":"2026","unstructured":"Lewis ACF, Brown G, Ahmed A, Afolabi M, Bedeker A, Boemer F, et al. Navigating ethical, legal and social implications in genomic newborn screening. Nat Rev Genet. 2026;27(4):265\u201366. https:\/\/doi.org\/10.1038\/s41576-026-00936-4.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"4513_CR238","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ajhg.2018.11.016","volume":"104","author":"O Ceyhan-Birsoy","year":"2019","unstructured":"Ceyhan-Birsoy O, Murry JB, Machini K, Lebo MS, Yu TW, Fayer S, et al. Interpretation of genomic sequencing results in healthy and ill newborns: results from the BabySeq project. Am J Hum Genet. 2019;104(1):76\u201393. https:\/\/doi.org\/10.1016\/j.ajhg.2018.11.016.","journal-title":"Am J Hum Genet"},{"issue":"7624","key":"4513_CR239","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/538161a","volume":"538","author":"AB Popejoy","year":"2016","unstructured":"Popejoy AB, Fullerton SM. Genomics is failing on diversity. Nature. 2016;538(7624):161\u201364. https:\/\/doi.org\/10.1038\/538161a.","journal-title":"Nature"},{"issue":"1","key":"4513_CR240","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s11568-014-0003-1","volume":"8","author":"BM Knoppers","year":"2014","unstructured":"Knoppers BM. Framework for responsible sharing of genomic and health-related data. HUGO J. 2014;8(1):3. https:\/\/doi.org\/10.1186\/s11568-014-0003-1.","journal-title":"The HUGO J"},{"issue":"9","key":"4513_CR241","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/s41591-020-0966-5","volume":"26","author":"AN Adhikari","year":"2020","unstructured":"Adhikari AN, Gallagher RC, Wang Y, Currier RJ, Amatuni G, Bassaganyas L, et al. The role of exome sequencing in newborn screening for inborn errors of metabolism. Nat Med. 2020;26(9):1392\u201397. https:\/\/doi.org\/10.1038\/s41591-020-0966-5.","journal-title":"Nat Med"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04513-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04513-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04513-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:24:50Z","timestamp":1792722290000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04513-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":241,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4513"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04513-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"7 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"374"}}